
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Phorbol esters induce PLVAP expression via VEGF and additional secreted molecules in MEK1&#8208;dependent and p38, JNK and PI3K/Akt&#8208;independent manner - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="322C300B24F3920500002AA15467F7FE.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="jcmmopen" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC6349158/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349158/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Journal of Cellular and Molecular Medicine" /><meta name="citation_title" content="Phorbol esters induce PLVAP expression via VEGF and additional secreted molecules in MEK1&#x02010;dependent and p38, JNK and PI3K/Akt&#x02010;independent manner" /><meta name="citation_author" content="B. JoNell Hamilton" /><meta name="citation_author_institution" content="Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire" /><meta name="citation_author_institution" content="Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire" /><meta name="citation_author" content="Dan Tse" /><meta name="citation_author_institution" content="Department of Pathology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire" /><meta name="citation_author" content="Radu V. Stan" /><meta name="citation_author_institution" content="Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire" /><meta name="citation_author_institution" content="Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire" /><meta name="citation_author_institution" content="Department of Pathology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire" /><meta name="citation_publication_date" content="2019/02" /><meta name="citation_issue" content="2" /><meta name="citation_volume" content="23" /><meta name="citation_firstpage" content="920" /><meta name="citation_doi" content="10.1111/jcmm.13993" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC6349158/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC6349158/" /><meta name="citation_pmid" content="30394679" /><meta name="DC.Title" content="Phorbol esters induce PLVAP expression via VEGF and additional secreted molecules in MEK1&#x02010;dependent and p38, JNK and PI3K/Akt&#x02010;independent manner" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Wiley" /><meta name="DC.Contributor" content="B. JoNell Hamilton" /><meta name="DC.Contributor" content="Dan Tse" /><meta name="DC.Contributor" content="Radu V. Stan" /><meta name="DC.Date" content="2019 Feb" /><meta name="DC.Identifier" content="10.1111/jcmm.13993" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Phorbol esters induce PLVAP expression via VEGF and additional secreted molecules in MEK1&#x02010;dependent and p38, JNK and PI3K/Akt&#x02010;independent manner" /><meta property="og:type" content="article" /><meta property="og:description" content="Endothelial diaphragms are subcellular structures critical for mammalian survival with poorly understood biogenesis. Plasmalemma vesicle associated protein () is the only known diaphragm component and is necessary for diaphragm formation. Very little ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349158/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6349158/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2233/">J Cell Mol Med</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/328370/">v.23(2); 2019 Feb</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC6349158
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC6349158/pdf/JCMM-23-920.pdf" class="int-view">PDF (1.2M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/6349158/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/6349158/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="6349158" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6349158%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="ED8sKITfeodK8luTDZM0IMD6S3rF1C1yr2HVXcpdH9eVqn0PWbGfHYwu3DLQopCx">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6349158%2F&amp;text=Phorbol%20esters%20induce%20PLVAP%20expression%20via%20VEGF%20and%20additional%20secreted%20molecules%20in%20MEK1%02010dependent%20and%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6349158%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349158/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC6349158/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/30394679/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC6349158/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/30394679/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC6349158/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/6349158/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2233/">J Cell Mol Med</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/328370/">v.23(2); 2019 Feb</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC6349158
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-jcmmopen.gif" alt="Logo of jcmmopen" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291582-4934" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">J Cell Mol Med.</span> 2019 Feb; 23(2): 920–933. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2018 Nov 5. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1111%2Fjcmm.13993" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1111/jcmm.13993</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC6349158</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30394679">30394679</a></div></div></div><h1 class="content-title">Phorbol esters induce <span style="fixed-case">PLVAP</span> expression via <span style="fixed-case">VEGF</span> and additional secreted molecules in <span style="fixed-case">MEK</span>1&#x02010;dependent and p38, <span style="fixed-case">JNK</span> and <span style="fixed-case">PI</span>3K/Akt&#x02010;independent manner</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hamilton%20BJ%5BAuthor%5D" id="jcmm13993-cr-0001" class="affpopup" co-rid="_co_idm140004595709856" co-class="co-affbox">B. JoNell Hamilton</a>,<sup>
1
,</sup><sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tse%20D%5BAuthor%5D" id="jcmm13993-cr-0002" class="affpopup" co-rid="_co_idm140004595707728" co-class="co-affbox">Dan Tse</a>,<sup>
3
</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Stan%20RV%5BAuthor%5D" id="jcmm13993-cr-0003" class="affpopup" co-rid="_co_idm140004595705120" co-class="co-affbox">Radu V. Stan</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>
1
,</sup><sup>
2
,</sup><sup>
3
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140004595709856"><h3 class="no_margin">B. JoNell Hamilton</h3><p>
<sup>1</sup>
Department of Biochemistry and Cell Biology, 
Geisel School of Medicine at Dartmouth, 
Lebanon, 
New Hampshire
</p><p>
<sup>2</sup>
Norris Cotton Cancer Center, 
Geisel School of Medicine at Dartmouth, 
Lebanon, 
New Hampshire
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hamilton%20BJ%5BAuthor%5D">B. JoNell Hamilton</a></div></div><div id="_co_idm140004595707728"><h3 class="no_margin">Dan Tse</h3><p>
<sup>3</sup>
Department of Pathology, 
Geisel School of Medicine at Dartmouth, 
Lebanon, 
New Hampshire
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tse%20D%5BAuthor%5D">Dan Tse</a></div></div><div id="_co_idm140004595705120"><h3 class="no_margin">Radu V. Stan</h3><p>
<sup>1</sup>
Department of Biochemistry and Cell Biology, 
Geisel School of Medicine at Dartmouth, 
Lebanon, 
New Hampshire
</p><p>
<sup>2</sup>
Norris Cotton Cancer Center, 
Geisel School of Medicine at Dartmouth, 
Lebanon, 
New Hampshire
</p><p>
<sup>3</sup>
Department of Pathology, 
Geisel School of Medicine at Dartmouth, 
Lebanon, 
New Hampshire
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Stan%20RV%5BAuthor%5D">Radu V. Stan</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140004636783008_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140004636783008_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140004636783008_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140004636783008_ai" style="display:none"><div class="fm-affl" id="jcmm13993-aff-0001">
<sup>1</sup>
Department of Biochemistry and Cell Biology, 
Geisel School of Medicine at Dartmouth, 
Lebanon, 
New Hampshire
</div><div class="fm-affl" id="jcmm13993-aff-0002">
<sup>2</sup>
Norris Cotton Cancer Center, 
Geisel School of Medicine at Dartmouth, 
Lebanon, 
New Hampshire
</div><div class="fm-affl" id="jcmm13993-aff-0003">
<sup>3</sup>
Department of Pathology, 
Geisel School of Medicine at Dartmouth, 
Lebanon, 
New Hampshire
</div><div><span class="fm-affl">Radu V. Stan, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.htuomtrad@nats.v.udar" class="oemail">ude.htuomtrad@nats.v.udar</a></span>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="correspondenceTo"><sup>*</sup><strong>Correspondence</strong><br />
Radu V. Stan, MD, PhD, Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Lebanon, NH.<br />
Email: <a href="mailto:dev@null" data-email="ude.htuomtrad@nats.v.udar" class="oemail">ude.htuomtrad@nats.v.udar</a><span style="unicode-bidi:bidi-override">, </span><br /></div></div><div class="fm-article-notes hide half_rhythm" id="idm140004636783008_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2018 Sep 10; Accepted 2018 Oct 4.</div></div><div class="permissions half_rhythm hide" id="idm140004636783008_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley &#x00026; Sons Ltd and Foundation for Cellular and Molecular Medicine.</div><div class="license half_rhythm">This is an open access article under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">&#x000a0;</div><div><a href="/pmc/articles/PMC6349158/bin/JCMM-23-920-s001.eps" data-ga-action="click_feat_suppl">JCMM-23-920-s001.eps</a><span style="color:gray"> (7.3M)</span></div><div class="small guid">GUID: E78EEB67-4818-4A27-9C15-67C7A9F6B7C1</div></div></dd></dl></div><div id="jcmm13993-abs-0001" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm13993-abs-0001title">Abstract</h2><!--article-meta--><div><p class="p p-first-last">Endothelial diaphragms are subcellular structures critical for mammalian survival with poorly understood biogenesis. Plasmalemma vesicle associated protein (<span style="fixed-case">PLVAP</span>) is the only known diaphragm component and is necessary for diaphragm formation. Very little is known about <span style="fixed-case">PLVAP</span> regulation. Phorbol esters (<span style="fixed-case">PMA</span>) are known to induce de novo <span style="fixed-case">PLVAP</span> expression and diaphragm formation. We show that this induction relies on the de novo production of soluble factors that will act in an autocrine manner to induce <span style="fixed-case">PLVAP</span> transcription and protein expression. We identified vascular endothelial growth factor&#x02010;A (<span style="fixed-case">VEGF</span>&#x02010;A) signalling through <span style="fixed-case">VEGFR</span>2 as a necessary but not sufficient downstream event as <span style="fixed-case">VEGF</span>&#x02010;A inhibition with antibodies and si<span style="fixed-case">RNA</span> or pharmacological inhibition of <span style="fixed-case">VEGFR</span>2 only partially inhibit <span style="fixed-case">PLVAP</span> upregulation. In terms of downstream pathways, inhibition of <span style="fixed-case">MEK</span>1/Erk1/2 <span style="fixed-case">MAP</span> kinase blocked <span style="fixed-case">PLVAP</span> upregulation, whereas inhibition of p38 and <span style="fixed-case">JNK MAP</span> kinases or <span style="fixed-case">PI</span>3K and Akt had no effect on <span style="fixed-case">PMA</span>&#x02010;induced <span style="fixed-case">PLVAP</span> expression. In conclusion, we show that <span style="fixed-case">VEGF</span>&#x02010;A along with other secreted proteins act synergistically to up&#x02010;regulate <span style="fixed-case">PLVAP</span> in <span style="fixed-case">MEK</span>1/Erk1/2 dependent manner, bringing us one step further into understanding the genesis of the essential structures that are endothelial diaphragms.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">cancer, caveolae, diapedesis, endothelial diaphragm, fenestrae, inflammation, permeability, transendothelial channel, <span style="fixed-case">VVO</span></span></div></div><div id="jcmm13993-sec-0001" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm13993-sec-0001title">1. INTRODUCTION</h2><p class="p p-first">Endothelial diaphragms<a href="#jcmm13993-bib-0001" rid="jcmm13993-bib-0001" class=" ref">1</a>, <a href="#jcmm13993-bib-0002" rid="jcmm13993-bib-0002" class=" ref">2</a> are ~40&#x02010;80&#x000a0;nm subcellular structures critical for life.<a href="#jcmm13993-bib-0003" rid="jcmm13993-bib-0003" class=" ref">3</a>, <a href="#jcmm13993-bib-0004" rid="jcmm13993-bib-0004" class=" ref">4</a>, <a href="#jcmm13993-bib-0005" rid="jcmm13993-bib-0005" class=" ref">5</a>, <a href="#jcmm13993-bib-0006" rid="jcmm13993-bib-0006" class=" ref">6</a>, <a href="#jcmm13993-bib-0007" rid="jcmm13993-bib-0007" class=" ref">7</a>, <a href="#jcmm13993-bib-0008" rid="jcmm13993-bib-0008" class=" ref">8</a> They occur in endothelial cells (EC) of capillaries and venules in select vascular beds (reviewed in<a href="#jcmm13993-bib-0002" rid="jcmm13993-bib-0002" class=" ref">2</a>). The diaphragms are thin protein barriers associated with endothelial specific microdomains (ie fenestrae, transendothelial channels, caveolae and vesiculo&#x02010;vacuolar organelles) with roles in the maintenance of vascular permeability, blood/tissue homeostasis<a href="#jcmm13993-bib-0003" rid="jcmm13993-bib-0003" class=" ref">3</a>, <a href="#jcmm13993-bib-0006" rid="jcmm13993-bib-0006" class=" ref">6</a> and the immune function.<a href="#jcmm13993-bib-0005" rid="jcmm13993-bib-0005" class=" ref">5</a>, <a href="#jcmm13993-bib-0009" rid="jcmm13993-bib-0009" class=" ref">9</a>, <a href="#jcmm13993-bib-0010" rid="jcmm13993-bib-0010" class=" ref">10</a>, <a href="#jcmm13993-bib-0011" rid="jcmm13993-bib-0011" class=" ref">11</a>
</p><p>Plasmalemma vesicle associated protein (PLVAP or PV1)<a href="#jcmm13993-bib-0012" rid="jcmm13993-bib-0012" class=" ref">12</a> is the only known molecular component of the diaphragms<a href="#jcmm13993-bib-0013" rid="jcmm13993-bib-0013" class=" ref">13</a>, <a href="#jcmm13993-bib-0014" rid="jcmm13993-bib-0014" class=" ref">14</a> and at cellular level, formation of diaphragms is the only function so far demonstrated for PLVAP.<a href="#jcmm13993-bib-0015" rid="jcmm13993-bib-0015" class=" ref">15</a> PLVAP knockdown in human<a href="#jcmm13993-bib-0016" rid="jcmm13993-bib-0016" class=" ref">16</a> or mouse<a href="#jcmm13993-bib-0017" rid="jcmm13993-bib-0017" class=" ref">17</a> cells results in endothelial diaphragms disappearance. Similarly, PLVAP deletion in mice<a href="#jcmm13993-bib-0003" rid="jcmm13993-bib-0003" class=" ref">3</a>, <a href="#jcmm13993-bib-0004" rid="jcmm13993-bib-0004" class=" ref">4</a>, <a href="#jcmm13993-bib-0005" rid="jcmm13993-bib-0005" class=" ref">5</a> or nonsense mutations in humans<a href="#jcmm13993-bib-0006" rid="jcmm13993-bib-0006" class=" ref">6</a>, <a href="#jcmm13993-bib-0007" rid="jcmm13993-bib-0007" class=" ref">7</a> lead to no diaphragm formation. The in&#x000a0;vivo loss of diaphragms results in failure of endothelial barrier function. Leakage of the plasma components into the interstitium of organs with fenestrated capillaries results in protein losing enteropathy, hypoproteinemia and hypertriglyceridemia causing a kwashiorkor&#x02010;like wasting syndrome and death.<a href="#jcmm13993-bib-0003" rid="jcmm13993-bib-0003" class=" ref">3</a>, <a href="#jcmm13993-bib-0006" rid="jcmm13993-bib-0006" class=" ref">6</a>
</p><p>Interestingly, PLVAP reconstitution in the endothelial compartment in mice restores diaphragms exclusively in EC in vascular beds where the diaphragms are native, demonstrating that additional factors are required for diaphragm formation.<a href="#jcmm13993-bib-0003" rid="jcmm13993-bib-0003" class=" ref">3</a>
</p><p>Very little is known on PLVAP and diaphragm regulation despite their importance. Phorbol esters such as phorbol myristate acetate (PMA) are known to induce robust de novo formation of fenestrae and transendothelial channels with their associated diaphragms in primary EC in culture.<a href="#jcmm13993-bib-0018" rid="jcmm13993-bib-0018" class=" ref">18</a> PMA also induces diaphragms of caveolae and PLVAP expression in MEK1&#x02010;dependent and PKC&#x02010;independent manner.<a href="#jcmm13993-bib-0016" rid="jcmm13993-bib-0016" class=" ref">16</a> Of note, PMA is also a known secretagogue in human EC.<a href="#jcmm13993-bib-0019" rid="jcmm13993-bib-0019" class=" ref">19</a>
</p><p>Vascular endothelial growth factor&#x02010;A (VEGF&#x02010;A) was also shown to be essential for formation and maintenance of fenestrae with diaphragms. VEGF&#x02010;A (and not FGF&#x02010;2 or VEGF&#x02010;C) induces new vessels with fenestrae with diaphragms<a href="#jcmm13993-bib-0020" rid="jcmm13993-bib-0020" class=" ref">20</a>, <a href="#jcmm13993-bib-0021" rid="jcmm13993-bib-0021" class=" ref">21</a>, <a href="#jcmm13993-bib-0022" rid="jcmm13993-bib-0022" class=" ref">22</a>, <a href="#jcmm13993-bib-0023" rid="jcmm13993-bib-0023" class=" ref">23</a>, <a href="#jcmm13993-bib-0024" rid="jcmm13993-bib-0024" class=" ref">24</a>, <a href="#jcmm13993-bib-0025" rid="jcmm13993-bib-0025" class=" ref">25</a> in Rac1 dependent manner.<a href="#jcmm13993-bib-0022" rid="jcmm13993-bib-0022" class=" ref">22</a> Deletion of VEGF&#x02010;A in the kidney podocytes, pancreas epithelial cells or hepatocytes<a href="#jcmm13993-bib-0026" rid="jcmm13993-bib-0026" class=" ref">26</a>, <a href="#jcmm13993-bib-0027" rid="jcmm13993-bib-0027" class=" ref">27</a>, <a href="#jcmm13993-bib-0028" rid="jcmm13993-bib-0028" class=" ref">28</a> or systemically delivered VEGFR2 inhibitors<a href="#jcmm13993-bib-0029" rid="jcmm13993-bib-0029" class=" ref">29</a> result in loss of fenestrae in mice. While overwhelmingly clear in the case of fenestrae, the effect of VEGF&#x02010;A/VEGFR2 signalling on PLVAP expression modulation seems to be context dependent. While a VEGFR2 receptor&#x02010;selective engineered form of VEGF&#x02010;A up&#x02010;regulates PLVAP expression in single donor human umbilical vein EC (HUVEC),<a href="#jcmm13993-bib-0030" rid="jcmm13993-bib-0030" class=" ref">30</a> primary EC cultured in presence of VEGF&#x02010;A do not or poorly express PLVAP<a href="#jcmm13993-bib-0016" rid="jcmm13993-bib-0016" class=" ref">16</a> and VEGF&#x02010;A has no effect<a href="#jcmm13993-bib-0017" rid="jcmm13993-bib-0017" class=" ref">17</a> or even decreases<a href="#jcmm13993-bib-0031" rid="jcmm13993-bib-0031" class=" ref">31</a> PLVAP expression in immortalized mouse EC lines that constitutively express PLVAP. Moreover, VEGFR2 signalling inhibition in&#x000a0;vivo does not modify PLVAP expression in the lung.<a href="#jcmm13993-bib-0032" rid="jcmm13993-bib-0032" class=" ref">32</a>
</p><p>Finally, the downregulation of PLVAP in specialized vascular beds forming the blood&#x02010;brain barrier,<a href="#jcmm13993-bib-0033" rid="jcmm13993-bib-0033" class=" ref">33</a>, <a href="#jcmm13993-bib-0034" rid="jcmm13993-bib-0034" class=" ref">34</a>, <a href="#jcmm13993-bib-0035" rid="jcmm13993-bib-0035" class=" ref">35</a>, <a href="#jcmm13993-bib-0036" rid="jcmm13993-bib-0036" class=" ref">36</a> or in developing arteries, glomeruli and cell culture<a href="#jcmm13993-bib-0037" rid="jcmm13993-bib-0037" class=" ref">37</a>, <a href="#jcmm13993-bib-0038" rid="jcmm13993-bib-0038" class=" ref">38</a>, <a href="#jcmm13993-bib-0039" rid="jcmm13993-bib-0039" class=" ref">39</a>, <a href="#jcmm13993-bib-0040" rid="jcmm13993-bib-0040" class=" ref">40</a> appear to be controlled by the Wnt and Notch signalling pathways respectively.</p><p class="p p-last">In order to arrive at a cell culture system where fenestrae with diaphragms and PLVAP could be induced at high frequency by physiological cues in primary EC, we have sought to dissect the molecular mechanism of PLVAP upregulation by PMA. We show that PMA upregulation of PLVAP mRNA and protein depends on de novo protein synthesis and secretion of a group of proteins that act synergistically in autocrine fashion. Among these secreted proteins, we identified VEGF&#x02010;A signalling through VEGFR2 as important but not sufficient for PLVAP expression. In addition, we show that PLVAP upregulation by the PMA&#x02010;induced secreted factors is MEK1&#x02010;dependent and JNK&#x02010;, p38&#x02010;, PI3K&#x02010; and Akt&#x02010;independent.</p></div><div id="jcmm13993-sec-0002" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm13993-sec-0002title">2. MATERIALS AND METHODS</h2><div id="jcmm13993-sec-0003" class="sec sec-first"><h3 id="jcmm13993-sec-0003title">2.1. Materials</h3><p class="p p-first">Recombinant human VEGF&#x02010;A was from R&#x00026;D Systems (Minneapolis, MN) (cat#293&#x02010;VE) or PreproTech (Rocky Hill, NJ), (cat#100&#x02010;20); Heparin&#x02010;Sepharose beads from GE Healthcare (Piscataway, NJ); PMA (cat# P8139) and cycloheximide (CHX) (cat# C4859) from Sigma (St. Louis, MO); pharmacological inhibitors, see Table&#x000a0;<a href="/pmc/articles/PMC6349158/table/jcmm13993-tbl-0001/" target="table" class="fig-table-link figpopup" rid-figpopup="jcmm13993-tbl-0001" rid-ob="ob-jcmm13993-tbl-0001" co-legend-rid=""><span>1</span></a>, from EMD Calbiochem (San Diego, CA) or SelleckChem (Houston, TX). All general reagents were from Thermo&#x02010;Fisher (Pittsburgh, PA), unless otherwise stated.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="jcmm13993-tbl-0001"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>Pharmacological inhibitors used in the study</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Name</th><th align="left" valign="top" rowspan="1" colspan="1">Concentration used</th><th align="left" valign="top" rowspan="1" colspan="1">Target selectivity (IC50 in cell&#x02010;free assays)</th><th align="left" valign="top" rowspan="1" colspan="1">Other known targets</th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1">VEGFR inhibitors</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Axitinib</td><td align="left" rowspan="1" colspan="1">1&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">VEGFR1 (0.1&#x000a0;nmol/L), VEGFR2 (0.2&#x000a0;nmol/L), VEGFR3 (0.2&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1">PDGFR&#x003b2; and c&#x02010;Kit</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Cabozantinib (XL184)</td><td align="left" rowspan="1" colspan="1">0.01&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">VEGFR2 (0.035&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1">c&#x02010;Met, Ret, Kit, Flt&#x02010;1/3/4, Tie2, AXL</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Vandetanib (ZD6474)</td><td align="left" rowspan="1" colspan="1">0.01&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">VEGFR2 (40&#x000a0;nmol/L), VEGFR3 (110&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1">EGFR</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SAR131675</td><td align="left" rowspan="1" colspan="1">1&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">VEGFR3 (23&#x000a0;nmol/L), VEGFR1 (1&#x000a0;&#x003bc;mol/L), VEGFR2 (200&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" colspan="4" rowspan="1">MEK1/2 inhibitors</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">U0126</td><td align="left" rowspan="1" colspan="1">0.01&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">MEK1/2 (70/60&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">PD98059</td><td align="left" rowspan="1" colspan="1">2.5&#x02010;25&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">MEK1 (2&#x000a0;&#x003bc;mol/L)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" colspan="4" rowspan="1">p38 inhibitors</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SB203580</td><td align="left" rowspan="1" colspan="1">1&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">p38&#x003b1;/&#x003b2; (300&#x02010;500&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1">Akt</td></tr><tr><td align="left" rowspan="1" colspan="1">SB202190 (FHPI)</td><td align="left" rowspan="1" colspan="1">1&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">p38&#x003b1; (50&#x000a0;nmol/L), p38&#x003b2; (100&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" colspan="4" rowspan="1">JNK inhibitors</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">SP600125</td><td align="left" rowspan="1" colspan="1">1&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">JNK1/2 (40&#x000a0;nmol/L), JNK3 (90&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1">Aurora A, TrkA, FLT3</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Tanzisertib (CC&#x02010;930)</td><td align="left" rowspan="1" colspan="1">1&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">JNK1 (61&#x000a0;nmol/L), JNK2/3 (5&#x000a0;nmol/L),</td><td align="left" rowspan="1" colspan="1">ERK1 and p38a</td></tr><tr><td align="left" colspan="4" rowspan="1">PI3K inhibitors</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pictilisib (GDC&#x02010;0941)</td><td align="left" rowspan="1" colspan="1">1&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">PI3K&#x003b1; (3&#x000a0;nmol/L), PI3K&#x003b2; (33&#x000a0;nmol/L), PI3K&#x003b4; (3&#x000a0;nmol/L), PI3K&#x003b3; (75&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1">mTOR</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Idelalisib (CAL&#x02010;101)</td><td align="left" rowspan="1" colspan="1">1&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">PI3K&#x003b4; (2.5&#x000a0;nmol/L), PI3K&#x003b3; (100&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1">C2&#x003b2;, hVPS34, DNA&#x02010;PK and mTOR</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Wortmannin</td><td align="left" rowspan="1" colspan="1">1&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">pan&#x02010;PI3K (3&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1">DNA&#x02010;PK, ATM, MLCK</td></tr><tr><td align="left" colspan="4" rowspan="1">Akt inhibitors</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ipatasertib (GDC&#x02010;0068)</td><td align="left" rowspan="1" colspan="1">1&#x02010;10&#x000a0;&#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">Akt1/2/3 (2/18/8&#x000a0;nmol/L)</td><td align="left" rowspan="1" colspan="1"></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140004599753984"><a target="object" rel="noopener" href="/pmc/articles/PMC6349158/table/jcmm13993-tbl-0001/?report=objectonly">Open in a separate window</a></div><div class="small permissions half_rhythm"></div></div></div><div id="jcmm13993-sec-0004" class="sec"><h3 id="jcmm13993-sec-0004title">2.2. Antibodies</h3><p class="p p-first-last">We used anti&#x02010;human PLVAP mAb (clone PAL&#x02010;E)<a href="#jcmm13993-bib-0006" rid="jcmm13993-bib-0006" class=" ref">6</a> and chicken anti&#x02010;human PLVAP&#x02010;C pAb<a href="#jcmm13993-bib-0041" rid="jcmm13993-bib-0041" class=" ref">41</a>; mouse anti&#x02010;GAPDH (clone 1E6D9, cat#60004&#x02010;1&#x02010;Ig, Proteintech, Rosemont, IL), mouse anti&#x02010;ACTB mAb (clone AC40; Sigma); rabbit anti&#x02010;human VEGF (clone 500&#x02010;P10, PeproTech and clone A&#x02010;20 Santa Cruz Biotechnology, Dallas, TX); mouse anti&#x02010;human VEGF (Ab&#x02010;1) from Neomarkers/Thermo Scientific (Pittsburgh, PA); phospho&#x02010;specific antibodies against MAP kinases (Erk1/2, p38, JNK) and Akt from Cell Signaling Technologies (Danvers, MA); IRDye680 and IRDye800&#x02010;secondary antibodies were from LiCOR (Lincoln, NE); HRP&#x02010;conjugated goat anti&#x02010;rabbit IgG&#x02010;HRP, rabbit anti&#x02010;chicken IgG&#x02010;HRP and goat anti&#x02010;mouse IgG&#x02010;HRP from Biodesign (Saco, ME).</p></div><div id="jcmm13993-sec-0005" class="sec"><h3 id="jcmm13993-sec-0005title">2.3. Cells and cell culture</h3><p class="p p-first-last">Human umbilical vein EC and neonate dermal microvascular EC (HDMVECn) were obtained from Lonza or PromoCell (Heidelberg, Germany) and were cultured according to manufacturer's instructions. HUVEC were cultured in EGM2, HDMVECn were cultured in EGM2&#x02010;MV (Lonza) or ECGM&#x02010;MV2 (PromoCell) medium. Cell culture certified bovine serum albumin (BSA) solution was purchased from Millipore&#x02010;Sigma (St. Louis, MO) (cat# A9576).</p></div><div id="jcmm13993-sec-0006" class="sec"><h3 id="jcmm13993-sec-0006title">2.4. PMA treatments</h3><p class="p p-first">Endothelial cells were seeded at 50%&#x02010;80% confluence in 1% gelatin (Sigma, cat# G9391)&#x02014;coated culture plates and grown to near confluence for 24&#x02010;48&#x000a0;hours in the manufacturer recommended growth media. Unless otherwise noted, EC were rinsed, and serum starved (2&#x000a0;hours, 37&#x000b0;C, 5%CO2) in EC basal medium (EBM2 or ECBM&#x02010;2) prior to PMA treatment.</p><div id="jcmm13993-sec-0007" class="sec"><p></p><h4 id="jcmm13993-sec-0007title" class="inline">2.4.1.  Chronic PMA treatment </h4><p class="p p-first-last">Endothelial cells were treated (37&#x000b0;C, 5% CO<sub>2</sub>) with 50&#x000a0;nmol/L PMA in EBM2 supplemented with 5% heat inactivated FBS (EBM&#x02010;FBS). After noted amounts of time, the PMA containing medium was aspirated, the cells rinsed twice in DPBS and processed for protein or RNA analysis.</p></div><div id="jcmm13993-sec-0008" class="sec sec-last"><p></p><h4 id="jcmm13993-sec-0008title" class="inline">2.4.2.  Pulsed PMA treatment </h4><p class="p p-first-last">Cells were &#x0201c;pulse stimulated&#x0201d; for 30&#x000a0;minutes (37&#x000b0;C, 5%CO<sub>2</sub>) with noted concentrations of PMA in 2% BSA in EBM2 (EBM&#x02010;BSA), the medium aspirated, the cells rinsed (2x, RT) with EBM2 and chased for the indicated time points. The chase medium consisted of either EBM&#x02010;BSA, EBM&#x02010;FBS or full growth medium. At indicated time points, supernatant and cells were harvested and further processed for protein or RNA analysis.</p></div></div><div id="jcmm13993-sec-0009" class="sec"><h3 id="jcmm13993-sec-0009title">2.5. Protein synthesis inhibition with cycloheximide</h3><p class="p p-first-last">For chronic PMA and for conditioned medium (CM) treatments, EC were seeded in duplicate on gelatin&#x02010;coated plates, grown to near confluence, serum starved 1.5&#x000a0;hours in EBM2 and 30&#x000a0;minutes presence of 10&#x000a0;&#x003bc;g/mL CHX in EBM&#x02010;BSA and stimulated for the duration of the experiment with 50&#x000a0;nmol/L PMA&#x000a0;+&#x000a0;10&#x000a0;&#x003bc;g/mL CHX or with 4&#x02010;6&#x000a0;hours CM&#x000a0;+&#x000a0;10&#x000a0;&#x003bc;g/mL CHX. For pulsed PMA treatment, the difference was that EC were stimulated with PMA/CHX for only 30&#x000a0;minutes followed by chase in EBM&#x02010;FBS containing 10&#x000a0;&#x003bc;g/mL CHX. At indicated time points, cells were rinsed twice in DPBS and lysed for RNA or protein analysis.</p></div><div id="jcmm13993-sec-0010" class="sec"><h3 id="jcmm13993-sec-0010title">2.6. Conditioned medium treatments</h3><p class="p p-first">For clarity, schematics of the experimental design are presented in the respective figures. Human EC (HUVEC or HDMVECn), labelled donor EC, were seeded at 70% density into gelatin&#x02010;coated six well plates and grown for 24&#x000a0;hours before serum starvation (2&#x000a0;hours, 37&#x000b0;C, 5% CO<sub>2</sub>, 2&#x000a0;mL per well) in EBM2 basal medium and pulse treatment (15&#x000a0;minutes, 37&#x000b0;C) with 1.5&#x000a0;mL per well of 50&#x000a0;nmol/L PMA or vehicle (DMSO) in EBM&#x02010;BSA. The drug was washed away with EBM2 medium (2x, RT, 2&#x000a0;mL per well), followed by donor EC incubation (37&#x000b0;C, 5% CO<sub>2</sub>, 1.5&#x000a0;mL per well) with EBM&#x02010;FBS. At the indicated time points, the EC CM containing EC secreted factors was collected and the donor cells further incubated (37&#x000b0;C, 5% CO<sub>2</sub>) in EBM&#x02010;FBS. At 24&#x000a0;hours after PMA treatment the donor cells were washed in DPBS and lysed for protein or RNA analysis.</p><p class="p">The CM from donor EC was immediately transferred onto PMA naive, serum starved (2&#x000a0;mL EBM2 per well, 2&#x000a0;hours, 37&#x000b0;C, 5% CO<sub>2</sub>), confluent acceptor EC grown on gelatin&#x02010;coated six well plates. Acceptor cells were incubated (37&#x000b0;C, 5% CO<sub>2</sub>) with CM for 24&#x000a0;hours, washed twice in DPBS and lysed for protein or RNA analysis.</p><div id="jcmm13993-sec-0011" class="sec"><p></p><h4 id="jcmm13993-sec-0011title" class="inline">2.6.1.  Heparin depletion of conditioned medium </h4><p class="p p-first-last">Conditioned medium peaks (4&#x02010;6 and 6&#x02010;8&#x000a0;hours) were collected from donor cells cultured in six well plates. For each peak the respective CM was pooled in a 15&#x000a0;mL tube and split into two halves. One half was left untreated (control), the other half of the volume was added to 1&#x000a0;mL settled gel of heparin&#x02010;agarose previously equilibrated (3&#x000d7;, 5&#x000a0;minutes, RT) in EBM&#x02010;BSA. The mixture was further incubated (1&#x000a0;hour, RT) with gentle end&#x02010;over&#x02010;end rotation before the beads were pelleted by centrifugation (600&#x000a0;<em>g</em>, 10&#x000a0;minutes, RT). Two mL per well control CM or heparin&#x02010;depleted CM was added to serum starved (2&#x000a0;hours, 37&#x000b0;C, 5% CO<sub>2</sub>) acceptor cells grown in duplicate wells in a six well plate, incubated (37&#x000b0;C, 5% CO<sub>2</sub>) for 24&#x000a0;hours when the acceptor cells were washed twice with DPBS and directly lysed in 200&#x000a0;&#x003bc;L per well of non&#x02010;reducing sample buffer. Equal volumes of the lysate were resolved by 8% SDS&#x02010;PAGE and subjected to immunoblotting with anti&#x02010;PLVAP and ACTB antibodies.</p></div><div id="jcmm13993-sec-0012" class="sec"><p></p><h4 id="jcmm13993-sec-0012title" class="inline">2.6.2.  Heat inactivation of CM </h4><p class="p p-first-last">Conditioned medium &#x0201c;peaks&#x0201d; were collected after PMA treatment and split into two equal volumes: one half was heat inactivated (45&#x000a0;minutes, 60&#x000b0;C followed by 2&#x000a0;minutes on ice) and the other one left untreated (control) before transfer to serum starved acceptor cells.</p></div><div id="jcmm13993-sec-0013" class="sec"><p></p><h4 id="jcmm13993-sec-0013title" class="inline">2.6.3.  Pertussis toxin treatment </h4><p class="p p-first-last">Acceptor cells were serum starved and then treated for 24&#x000a0;hours with CM in presence or absence of 0.1&#x000a0;&#x003bc;g/mL pertussis toxin (PT) (Sigma, cat# P7208).</p></div><div id="jcmm13993-sec-0014" class="sec sec-last"><p></p><h4 id="jcmm13993-sec-0014title" class="inline">2.6.4.  CM fractionation by ultracentrifugation </h4><p class="p p-first-last">Conditioned medium &#x0201c;peaks&#x0201d; (4&#x02010;6&#x000a0;hours) were collected and subjected to ultracentrifugation (1&#x000a0;hour, 100&#x000a0;000&#x000a0;<em>g</em>, 4&#x000b0;C). The supernatant (S), containing the soluble factors, was transferred to serum starved acceptor cells and further incubated for 24&#x000a0;hours (37&#x000b0;C, 5% CO<sub>2</sub>). The pellet (P), containing any particulate matter (exosomes) was resuspended in an equivalent volume of EBM&#x02010;FBS by pipetting and vortexing and transferred to donor cells.</p></div></div><div id="jcmm13993-sec-0015" class="sec"><h3 id="jcmm13993-sec-0015title">2.7. Inhibition of VEGF&#x02010;A signalling using anti&#x02010;VEGF&#x02010;A antibodies</h3><p class="p p-first-last">Conditioned medium &#x0201c;peaks&#x0201d; (4&#x02010;6 and 6&#x02010;8&#x000a0;hours) containing EC secreted factors were collected after PMA treatment. The CM peaks adjusted to 0.1 or 1&#x000a0;&#x003bc;g/mL of control or anti&#x02010;VEGF antibodies, incubated (1&#x000a0;hour, RT) with gentle rotation, added to PMA naive acceptor EC which were further cultured (24&#x000a0;hours, 37&#x000b0;C, 5% CO<sub>2</sub>) and collected for protein isolation and WB with anti&#x02010;PLVAP and ACTB antibodies.</p></div><div id="jcmm13993-sec-0016" class="sec"><h3 id="jcmm13993-sec-0016title">2.8. Pharmacological inhibition of downstream signalling of PMA and PMA conditioned medium</h3><p class="p p-first">Endothelial cells were seeded in six well plates, grown (24&#x000a0;hours, 37&#x000b0;C, 5% CO<sub>2</sub>) to confluence in full growth medium, serum starved for 90&#x000a0;minutes in EBM2, treated with the inhibitors in EBM2 for 30&#x000a0;minutes before adding PMA &#x000b1; inhibitors in EBM&#x02010;BSA and chased in EBM&#x02010;FBS for indicated times when cells were rinsed and processed for RNA or protein analysis. The specificity, IC50 and concentration range tested for each inhibitor are given in Table&#x000a0;<a href="/pmc/articles/PMC6349158/table/jcmm13993-tbl-0001/" target="table" class="fig-table-link figpopup" rid-figpopup="jcmm13993-tbl-0001" rid-ob="ob-jcmm13993-tbl-0001" co-legend-rid=""><span>1</span></a>. All the inhibitor stocks were freshly made as 1000&#x000d7; working stocks in EBM2 right before the experiment.</p><p class="p p-last">Conditioned medium peaks were collected, adjusted to the final concentrations of different inhibitors and added to serum starved naive acceptor EC that were preincubated (10&#x000a0;minutes, 37&#x000b0;C, 5% CO<sub>2</sub>) with the same concentration of the respective inhibitors. After the indicated times, acceptor cells were collected for RNA or protein isolation. For immunoblotting, cells were solubilized (5&#x000a0;minutes, 100&#x000b0;C) in SDS&#x02010;PAGE sample buffer containing 2% beta&#x02010;mercaptoethanol and 1&#x000a0;mmol/L NaVO<sub>4</sub>. The phosphorylation status of relevant enzymes was determined with the respective phospho&#x02010;specific antibodies.</p></div><div id="jcmm13993-sec-0017" class="sec"><h3 id="jcmm13993-sec-0017title">2.9. CM/CM experiments</h3><p class="p p-first-last">4&#x02010;6&#x000a0;hours CM was generated from donor cells and used in a pulse experiment (30&#x000a0;minutes, 37&#x000b0;C, 5% CO<sub>2</sub>) on serum starved (2&#x000a0;hours, 37&#x000b0;C in EBM2) naive acceptor cells. After incubation, the 4&#x02010;6&#x000a0;hours CM was aspirated from acceptor cells, the cells rinsed 2&#x000d7; with room temperature EBM2 and the cells chased in EBM&#x02010;FBS. Every 2&#x000a0;hours (ie at 2, 4, 6 and 8&#x000a0;hours) the 4&#x02010;6&#x000a0;hours CM conditioned medium (labelled conditioned medium/conditioned medium [CM/CM] medium) was collected and replaced with fresh EBM&#x02010;FBS. The peaks thus collected (ie 0&#x02010;2, 2&#x02010;4, 4&#x02010;6 and 6&#x02010;8&#x000a0;hours CM/CM) were&#x000a0;immediately transferred to serum starved (2&#x000a0;hours, 37&#x000b0;C in EBM2) naive HDMVECn and incubated for 24&#x000a0;hours when the cells were collected for PLVAP mRNA level evaluation by real&#x02010;time PCR.</p></div><div id="jcmm13993-sec-0018" class="sec"><h3 id="jcmm13993-sec-0018title">2.10. Multiplex cytokine assays</h3><p class="p p-first-last">Cytokines were measured in CM using Bio&#x02010;Plex human cytokine multiplex kits (Bio&#x02010;Rad, Hercules, CA) by DartLab core facility at Dartmouth.</p></div><div id="jcmm13993-sec-0019" class="sec"><h3 id="jcmm13993-sec-0019title">2.11. RNA isolation</h3><p class="p p-first-last">Total RNA was isolated using RNAeasy mini kit (Qiagen, Germantown, MD) or Quick RNA Mini&#x02010;prep Kit (Zymo Research, Irvine, CA), as per manufacturer's instructions. RNA integrity and quality were determined using Bioanalyzer (Agilent, Santa Clara, CA) and NanoDrop (Thermo&#x02010;Fisher). RNA preps with <em>A</em>260/280 ratios ranging from 1.97 to 2.02 were used.</p></div><div id="jcmm13993-sec-0020" class="sec"><h3 id="jcmm13993-sec-0020title">2.12. Real&#x02010;time quantitative PCR</h3><p class="p p-first">Quantitative real&#x02010;time PCR was done as before.<a href="#jcmm13993-bib-0015" rid="jcmm13993-bib-0015" class=" ref">15</a> Briefly, 2&#x000a0;&#x003bc;g of total RNA was reverse transcribed using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Real&#x02010;time PCR employing TaqMan Gene Expression Master Mix and Gene Expression Assays was carried out on an ABI 7500 RT&#x02010;PCR system (Applied Biosystems). The gene expression assays used were:&#x000a0;PLVAP (Hs00229941_m1), VEGF&#x02010;A (Hs00900055_m1), VEGFR1 (Hs01052961_m1), VEFR2 (Hs00911700_m1) and ACTB (Hs03023880_g1). The reactions were performed in triplicate, utilizing cDNA corresponding to 10&#x000a0;ng RNA input. Cycling conditions were as follows: cycle 1: step 1&#x02014;50&#x000b0;C for 2&#x000a0;minutes, step 2&#x02014;95&#x000b0;C for 10&#x000a0;minutes; cycles 2&#x02013;40: step 1&#x02014;95&#x000b0;C for 15&#x000a0;seconds and step 2&#x02014;60&#x000b0;C for 1&#x000a0;minute.</p><p>For multiplex quantitative real time PCR, reverse transcription was performed on 200&#x000a0;ng RNA using QuantiNova Kit (Qiagen). Triplex qPCR was performed in duplicate using Luna Universal Probe qPCR Master Mix (New England Biolabs, Ipswich, MA) to determine levels of PLVAP, VEGF, VEGFR1 and VEGFR2 mRNA (Table&#x000a0;<a href="/pmc/articles/PMC6349158/table/jcmm13993-tbl-0002/" target="table" class="fig-table-link figpopup" rid-figpopup="jcmm13993-tbl-0002" rid-ob="ob-jcmm13993-tbl-0002" co-legend-rid=""><span>2</span></a>). Human beta&#x02010;2&#x02010;microglobulin (B2M) was used as a housekeeping gene. PCR was run on BioRad CFX96 thermal cycler performed with the following conditions: cycle #1&#x02014;step 1 95&#x000b0;C for 10&#x000a0;minutes; cycles #2&#x02010;40&#x02014;step 1: 95&#x000b0;C for 15&#x000a0;seconds, step 2: 60&#x000b0;C for 1&#x000a0;minute.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="jcmm13993-tbl-0002"><h3>Table 2</h3><!--caption a7--><div class="caption"><p>Gene expression assays (IDT) used for multiplex real&#x02010;time PCR</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Gene</th><th align="left" valign="top" rowspan="1" colspan="1">Assay ID</th><th align="left" valign="top" rowspan="1" colspan="1">Fluor</th><th align="left" valign="top" rowspan="1" colspan="1">Probe</th><th align="left" valign="top" rowspan="1" colspan="1">Forward</th><th align="left" valign="top" rowspan="1" colspan="1">Reverse</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">B2M</td><td align="left" rowspan="1" colspan="1">Hs.PT.58v.18759587</td><td align="left" rowspan="1" colspan="1">HEX</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;/5HEX/CCTGCCGTG/ZEN/TG AACCATGTGACT/3IABkFQ/&#x02010;3&#x02032;</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;ACCTCCATGA TGCTGCTTAC&#x02010;3&#x02032;</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;GGACTGGTCTT TCTATCTCTTGT&#x02010;3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1">PLVAP</td><td align="left" rowspan="1" colspan="1">Hs.PT.58.39466084</td><td align="left" rowspan="1" colspan="1">Cy5</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;/5Cy5/CCAACCCCC/TAO/AG CCCATCGA/3IAbRQSp/&#x02010;3&#x02032;</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;GGATCTTCCTC TTGAACTCCTC&#x02010;3&#x02032;</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;TGGACACCT GCATCAAGAC&#x02010;3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1">VEGF&#x02010;A</td><td align="left" rowspan="1" colspan="1">Hs.PT.58.21234833</td><td align="left" rowspan="1" colspan="1">FAM</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;/56&#x02010;FAM/TGCTCTACC/ZEN/T CCACCATGCCAAG/3IABkFQ/&#x02010;3&#x02032;</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;GCGCTGATAG ACATCCATGA&#x02010;3&#x02032;</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;CCATGAACTTTC TGCTGTCTTG&#x02010;3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1">VEGFR1</td><td align="left" rowspan="1" colspan="1">Hs.PT.58.40906831</td><td align="left" rowspan="1" colspan="1">FAM</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;/56&#x02010;FAM/CGAGCAGAT/ZEN/T TCTCAGTCGCAGGTA/3IABkFQ/&#x02010;3&#x02032;</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;CATCCTCTTCA GTTACGTCCTT&#x02010;3&#x02032;</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;GCTCTCTATGAA AGTGAAGGCA&#x02010;3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1">VEGFR2</td><td align="left" rowspan="1" colspan="1">Hs.PT.58.3285240</td><td align="left" rowspan="1" colspan="1">FAM</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;/56&#x02010;FAM/AGAAGGAGC/ZEN/A ACACACAGTGAGCA/3IABkFQ/&#x02010;3&#x02032;</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;GAGGATCTTGA GTTCAGACATGG&#x02010;3&#x02032;</td><td align="left" rowspan="1" colspan="1">5&#x02032;&#x02010;TTGGAATTGACA AGACAGCAAC&#x02010;3&#x02032;</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140004636987920"><a target="object" rel="noopener" href="/pmc/articles/PMC6349158/table/jcmm13993-tbl-0002/?report=objectonly">Open in a separate window</a></div><div class="small permissions half_rhythm"></div></div><p class="p p-last">Gene expression was quantitated performed with both absolute and relative methods, as described.<a href="#jcmm13993-bib-0042" rid="jcmm13993-bib-0042" class=" ref">42</a> For absolute quantification, the PCR signal of each gene was compared to the signal obtained using standard curves generated using five 10&#x02010;fold serial dilutions (100&#x000a0;000 to 10 copies) of constructs containing the gene expression assay target sequence cloned into the pGEM&#x02010;T vector (Promega, Madison, WI). For each gene, the copy number&#x000a0;&#x000d7;&#x000a0;Ct (threshold cycle) was plotted and the curve used to calculate the copy number in each sample. In addition, fold difference over the non&#x02010;treated control (NTC) was calculated as follows: FD (fold difference)&#x000a0;=&#x000a0;2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> in which &#x00394;&#x00394;Ct&#x000a0;=&#x000a0;&#x00394;Ct&#x02212;(4&#x000a0;hours NTC &#x00394;Ct) and &#x00394;Ct&#x000a0;=&#x000a0;(target RNA Ct)&#x02212;(calibrator Ct) where calibrator was either ACTB or B2M.</p></div><div id="jcmm13993-sec-0021" class="sec"><h3 id="jcmm13993-sec-0021title">2.13. RT&#x02010;PCR for VEGFA isoforms</h3><p class="p p-first-last">Total RNA (200&#x000a0;ng) from control and PMA treated HDMVECn was reverse transcribed and human VEGF&#x02010;A isoforms were amplified using forward (5&#x02032;&#x02010;TGCGGATCAAACCTCACCAA&#x02010;3&#x02032;) and reverse (5&#x02032;&#x02010;CCTCCGGACCCAAAGTGCT&#x02010;3&#x02032;) primers located in exons 4 and 8b of the human VEGF&#x02010;A gene, respectively. Primer sequences and PCR amplification conditions were as described.<a href="#jcmm13993-bib-0043" rid="jcmm13993-bib-0043" class=" ref">43</a> The expected PCR amplicon sizes were: 319 nucleotides for VEGF&#x02010;A&#x02010;121 (NCBI transcript <a id="__tag_832927082" class="tag_hotlink" href="/nuccore/NM_001025370.2" ref="/nuccore/NM_001025370.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_001025370.2","term_id":"284172454","term_text":"NM_001025370.2"}}</span>NM_001025370.2</a>), 451 nucleotides for VEGF&#x02010;A&#x02010;165 (NCBI transcript <a id="__tag_832927083" class="tag_hotlink" href="/nuccore/NM_001025368.2" ref="/nuccore/NM_001025368.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_001025368.2","term_id":"284172452","term_text":"NM_001025368.2"}}</span>NM_001025368.2</a>), 523 nucleotides for VEGF&#x02010;A&#x02010;189 (NCBI transcript <a id="__tag_832927081" class="tag_hotlink" href="/nuccore/NM_001171624.1" ref="/nuccore/NM_001171624.1"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_001171624.1","term_id":"284172460","term_text":"NM_001171624.1"}}</span>NM_001171624.1</a>).</p></div><div id="jcmm13993-sec-0022" class="sec"><h3 id="jcmm13993-sec-0022title">2.14. Western blotting</h3><p class="p p-first">Cells were placed on ice, rinsed twice with ice&#x02010;cold PBS, and lysed in 10&#x000a0;mmol/L Tris&#x02010;Cl, pH 6.8 containing 0.5% SDS and protease inhibitors cocktail (P8340&#x02014;Sigma&#x02010;Aldrich). Detergent extracts were cleared by centrifugation (10&#x000a0;minutes, 16&#x000b0;C, 16&#x000a0;000&#x000a0;<em>g</em>) and protein concentration determined using the bicinchoninic acid protein assay (Thermo&#x02010;Fisher). Equal amounts (20&#x000a0;&#x003bc;g per lane) of total EC proteins were heated 5&#x000a0;minutes at 100&#x000b0;C in SDS&#x02010;PAGE sample buffer, resolved by SDS&#x02010;PAGE and electro&#x02010;transferred to PVDF membrane (Millipore&#x02010;Sigma). In some experiments, cells were lysed directly in SDS&#x02010;PAGE non&#x02010;reducing sample buffer and processed as above.</p><p>PVDF membranes containing EC proteins were blocked (30&#x000a0;minutes, RT) with blocking buffer (LiCOR), incubated (overnight, 4&#x000b0;C) with primary antibodies diluted in blocking buffer, washed (3&#x000a0;&#x000d7;&#x000a0;5&#x000a0;minutes, RT) in PBS, and incubated (30&#x000a0;minutes, RT) with either HRP&#x02010; or IRDye&#x02010;680 or &#x02010;800 (LiCOR) labelled secondary antibodies. For HRP&#x02010;labelled secondary antibodies, the signal was generated using SuperSignal West chemiluminescent substrates (Thermo&#x02010;Fisher) and images acquired using a G:Box&#x000a0;Chemi XT16 imaging system and GeneSnap software (Syngene, Frederick, MD). The near infrared signal of the IRDye&#x02010;labelled antibodies was detected with an Odyssey fluorescence scanner (LiCOR).</p><p class="p p-last">Equal loading of lanes was confirmed by blotting membranes with antibodies against housekeeping genes such as of mouse anti&#x02010;ACTB mAb (clone AC40) and mouse anti&#x02010;GAPDH mAb (clone 1E6D9). Signal quantitation by densitometry on TIFF files was carried out using GelEval v1.35 software (FrogDance, UK) or ImageStudio Lite (LiCOR).</p></div><div id="jcmm13993-sec-0023" class="sec sec-last"><h3 id="jcmm13993-sec-0023title">2.15. Statistics</h3><p class="p p-first-last">Data were analysed using Student's <em>t</em> test. <em>P</em>&#x000a0;&#x0003c;&#x000a0;0.05 was taken as the level of significance.</p></div></div><div id="jcmm13993-sec-0024" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm13993-sec-0024title">3. RESULTS</h2><div id="jcmm13993-sec-0025" class="sec sec-first"><h3 id="jcmm13993-sec-0025title">3.1. Upregulation of PLVAP mRNA by PMA requires protein translation</h3><p class="p p-first">In a first step, we asked whether PMA&#x02010;induced PLVAP mRNA transcription depended on de novo protein synthesis. To answer this, we treated primary human HDMVECn with 50&#x000a0;nmol/L PMA (concentration demonstrated to up&#x02010;regulate PLVAP and induce the formation of endothelial diaphragms and fenestrae<a href="#jcmm13993-bib-0016" rid="jcmm13993-bib-0016" class=" ref">16</a>) in presence or absence of CHX, a protein synthesis inhibitor.<a href="#jcmm13993-bib-0044" rid="jcmm13993-bib-0044" class=" ref">44</a> As shown previously,<a href="#jcmm13993-bib-0016" rid="jcmm13993-bib-0016" class=" ref">16</a> cells were exposed to PMA for the entire duration of the experiment. PLVAP ****mRNA significantly increased in time&#x02010;dependent manner starting at ~2&#x000a0;hours after PMA treatment onset (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0001" rid-ob="ob-jcmm13993-fig-0001" co-legend-rid="lgnd_jcmm13993-fig-0001"><span>1</span></a>A). However, there was no increase of PLVAP mRNA or protein (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0001" rid-ob="ob-jcmm13993-fig-0001" co-legend-rid="lgnd_jcmm13993-fig-0001"><span>1</span></a>B) when cells were treated with PMA in presence CHX for up to 8&#x000a0;hours of treatment, demonstrating that PLVAP upregulation by PMA requires de novo protein synthesis.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm13993-fig-0001" co-legend-rid="lgnd_jcmm13993-fig-0001"><a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0001/" target="figure" rid-figpopup="jcmm13993-fig-0001" rid-ob="ob-jcmm13993-fig-0001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140004590803056"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g001.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g001.jpg" src="/pmc/articles/PMC6349158/bin/JCMM-23-920-g001.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140004590803056"><a target="object" rel="noopener" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm13993-fig-0001"><div><a class="figpopup" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0001/" target="figure" rid-figpopup="jcmm13993-fig-0001" rid-ob="ob-jcmm13993-fig-0001">Figure 1</a></div><!--caption a7--><div class="caption"><p>Plasmalemma vesicle associated protein (<span style="fixed-case">PLVAP</span>) <span style="fixed-case">mRNA</span> upregulation by phorbol myristate acetate (<span style="fixed-case">PMA</span>) requires protein synthesis. (A) Relative <span style="fixed-case">PLVAP mRNA</span> levels as determined by real time <span style="fixed-case">PCR</span> and quantitated using the 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> method. Total <span style="fixed-case">RNA</span> from non&#x02010;treated control <span style="fixed-case">EC</span> (time 0) or <span style="fixed-case">EC</span> treated for 2, 4 or 8&#x000a0;h with 50&#x000a0;nmol/L <span style="fixed-case">PMA</span> (solid line) or 50&#x000a0;nmol/L <span style="fixed-case">PMA</span>+10&#x000a0;&#x003bc;mol/L <span style="fixed-case">CHX</span> (dashed line) were reverse transcribed and probed with validated <span style="fixed-case">PLVAP</span> and <span style="fixed-case">ACTB</span> Taqman gene assays. (B) Immunoblotting with chicken anti&#x02010;human <span style="fixed-case">PV</span>1 C <span style="fixed-case">pA</span>b (top panel) and anti&#x02010;<span style="fixed-case">ACTB mA</span>b (lower panel) of <span style="fixed-case">EC</span> lysates treated with 50&#x000a0;nmol/L <span style="fixed-case">PMA</span>&#x000a0;&#x000b1;&#x000a0;10&#x000a0;&#x003bc;g/mL cycloheximide for 4 or 8&#x000a0;h. <span style="fixed-case">EC</span> lysates treated with 50&#x000a0;nmol/L <span style="fixed-case">PMA</span> for 24&#x000a0;h were used as positive control for <span style="fixed-case">PMA</span> induction of PLVAP</p></div></div></div></div><div id="jcmm13993-sec-0026" class="sec"><h3 id="jcmm13993-sec-0026title">3.2. PLVAP is up&#x02010;regulated by PMA&#x02010;induced soluble proteins</h3><p class="p p-first">We next asked whether the newly synthesized proteins needed to be secreted and possibly acted in autocrine fashion. First, we showed that a 30&#x02010;minute pulse of 50&#x000a0;nmol/L PMA followed by its removal and chase using a defined medium elicits similar levels of PLVAP protein at 24&#x000a0;hours post stimulation when compared to 24&#x000a0;hours &#x0201c;chronic&#x0201d; PMA treatment (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0002" rid-ob="ob-jcmm13993-fig-0002" co-legend-rid="lgnd_jcmm13993-fig-0002"><span>2</span></a>A) with the highest levels of PLVAP protein sustained by EBM&#x02010;FBS or EGM as chase medium (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0002" rid-ob="ob-jcmm13993-fig-0002" co-legend-rid="lgnd_jcmm13993-fig-0002"><span>2</span></a>A). Peak response was observed at 8&#x000a0;hours post pulse at doses &#x02265;5&#x000a0;nmol/L PMA but remained high at 24&#x000a0;hours only for doses of &#x02265;25&#x000a0;nmol/L (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0002" rid-ob="ob-jcmm13993-fig-0002" co-legend-rid="lgnd_jcmm13993-fig-0002"><span>2</span></a>C). Based on these results, a 30&#x000a0;minutes pulse of 50&#x000a0;nmol/L PMA stimulation of EC and using EBM&#x02010;FBS as chase medium was selected for the CM preparation.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm13993-fig-0002" co-legend-rid="lgnd_jcmm13993-fig-0002"><a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0002/" target="figure" rid-figpopup="jcmm13993-fig-0002" rid-ob="ob-jcmm13993-fig-0002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140004591344304"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g002.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g002.jpg" src="/pmc/articles/PMC6349158/bin/JCMM-23-920-g002.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140004591344304"><a target="object" rel="noopener" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm13993-fig-0002"><div><a class="figpopup" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0002/" target="figure" rid-figpopup="jcmm13993-fig-0002" rid-ob="ob-jcmm13993-fig-0002">Figure 2</a></div><!--caption a7--><div class="caption"><p>A short pulse of phorbol myristate acetate (<span style="fixed-case">PMA</span>) induces plasmalemma vesicle associated protein (<span style="fixed-case">PLVAP</span>) <span style="fixed-case">mRNA</span> and protein in time&#x02010; and dose&#x02010;dependent manner. (A) <span style="fixed-case">PMA</span> up&#x02010;regulates <span style="fixed-case">PLVAP</span> protein in serum dependent manner. Left&#x02014;Western blotting with anti&#x02010;<span style="fixed-case">PLVAP</span> and &#x02010;<span style="fixed-case">GAPDH</span> antibodies of <span style="fixed-case">HDMVEC</span> lysates treated with 50&#x000a0;nmol/L <span style="fixed-case">PMA</span> for 30&#x000a0;min or 24&#x000a0;h. The samples were chased or treated, respectively, in <span style="fixed-case">EBM</span>&#x02010;<span style="fixed-case">BSA</span> (B), <span style="fixed-case">EBM</span>&#x02010;<span style="fixed-case">FBS</span> (F) or full growth medium (<span style="fixed-case">GM</span>). Right &#x02010; quantitation of the Western blotting signal (<span style="fixed-case">SEM</span>, n&#x000a0;&#x0003e;&#x000a0;3, *<em>P</em>&#x000a0;&#x0003c;&#x000a0;0.05). For all treatments there was a statistically significant increase in <span style="fixed-case">PLVAP</span> levels in <span style="fixed-case">PMA</span> treated samples versus <span style="fixed-case">NTC</span> and between <span style="fixed-case">EBM</span>&#x02010;<span style="fixed-case">BSA</span> versus <span style="fixed-case">EBM</span>&#x02010;<span style="fixed-case">FBS</span> or <span style="fixed-case">GM</span>. No statistically significant difference was found between the two treatments for <span style="fixed-case">EBM</span>&#x02010;<span style="fixed-case">FBS</span> and <span style="fixed-case">GM</span>. (B) Immunoblotting with anti&#x02010;<span style="fixed-case">PLVAP</span> and &#x02010;<span style="fixed-case">GAPDH</span> antibodies of <span style="fixed-case">HDMVEC</span> lysates treated with the noted concentrations of <span style="fixed-case">PMA</span> for 30&#x000a0;min (left) and quantitation of the Western blotting signal (right). (C) Relative <span style="fixed-case">PLVAP</span>/B2M <span style="fixed-case">mRNA</span> levels induced by different concentrations of <span style="fixed-case">PMA</span>. Data are expressed as relative <span style="fixed-case">mRNA</span> levels by &#x00394;&#x00394;Ct method (left) and ratio of <span style="fixed-case">mRNA</span> copy numbers (right) relative to beta 2 microglobulin gene (B2M). All <span style="fixed-case">PMA</span> treated samples had a statistically significant increase in <span style="fixed-case">PLVAP mRNA</span> compared to <span style="fixed-case">NTC</span> (<span style="fixed-case">SEM</span>, n&#x000a0;=&#x000a0;3, *<em>P</em>&#x000a0;&#x0003c;&#x000a0;0.05)</p></div></div></div><p>Serum starved (2&#x000a0;hours, 37&#x000b0;C, 5% CO<sub>2</sub>) naive acceptor EC (schematic in Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0003" rid-ob="ob-jcmm13993-fig-0003" co-legend-rid="lgnd_jcmm13993-fig-0003"><span>3</span></a>A) were treated (24&#x000a0;hours, 37&#x000b0;C, 5% CO<sub>2</sub>) with CM collected from donor cells at 1, 2, 4, and 8&#x000a0;hours post&#x02010;PMA pulse. The 8&#x000a0;hours CM was the most potent in upregulating PLVAP protein in naive acceptor EC (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0003" rid-ob="ob-jcmm13993-fig-0003" co-legend-rid="lgnd_jcmm13993-fig-0003"><span>3</span></a>B, right) demonstrating that between 4&#x02010;8&#x000a0;hours after PMA pulse, donor ECs secrete factors capable of robustly upregulating PLVAP. Heat induced denaturation severely reduced the CM ability to induce PLVAP (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0003" rid-ob="ob-jcmm13993-fig-0003" co-legend-rid="lgnd_jcmm13993-fig-0003"><span>3</span></a>E), confirming the&#x000a0;protein nature of the secreted factors. All donor EC showed the&#x000a0;expected PMA&#x02010;induced upregulation of PLVAP at 24&#x000a0;hours (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0003" rid-ob="ob-jcmm13993-fig-0003" co-legend-rid="lgnd_jcmm13993-fig-0003"><span>3</span></a>B, left), further supporting these conclusions.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm13993-fig-0003" co-legend-rid="lgnd_jcmm13993-fig-0003"><a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0003/" target="figure" rid-figpopup="jcmm13993-fig-0003" rid-ob="ob-jcmm13993-fig-0003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140004599740576"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g003.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g003.jpg" src="/pmc/articles/PMC6349158/bin/JCMM-23-920-g003.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140004599740576"><a target="object" rel="noopener" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm13993-fig-0003"><div><a class="figpopup" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0003/" target="figure" rid-figpopup="jcmm13993-fig-0003" rid-ob="ob-jcmm13993-fig-0003">Figure 3</a></div><!--caption a7--><div class="caption"><p>Phorbol myristate acetate (<span style="fixed-case">PMA</span>) induces timed secretion of heat sensitive factor(s) that up&#x02010;regulate plasmalemma vesicle associated protein (<span style="fixed-case">PLVAP</span>) in naive acceptor endothelial cells (<span style="fixed-case">EC</span>). (A, B) Schematic of the experimental set&#x02010;up (A) and immunoblotting of <span style="fixed-case">EC</span> lysates (B) with anti&#x02010;<span style="fixed-case">PLVAP</span> (top panel) and <span style="fixed-case">ACTB</span> (lower panel) antibodies. Donor cells were treated with a pulse of 50&#x000a0;nmol/L <span style="fixed-case">PMA</span> and the conditioned medium (CM) was collected after 1, 2, 4, or 8&#x000a0;h and immediately transferred onto naive acceptor <span style="fixed-case">EC</span>. (C, D) Schematic of the experimental set&#x02010;up (C) and immunoblotting of <span style="fixed-case">EC</span> lysates (D) with anti&#x02010;<span style="fixed-case">PLVAP</span> (top panel) and <span style="fixed-case">ACTB</span> (lower panel) antibodies. Donor cells were treated with a pulse of 50&#x000a0;nmol/L <span style="fixed-case">PMA</span> and the CM was collected between 0&#x02010;1, 3&#x02010;4, 5&#x02010;6, or 7&#x02010;8&#x000a0;h and immediately transferred onto naive acceptor <span style="fixed-case">EC</span> which were incubated for 24&#x000a0;h, lysed and subjected to immunoblotting. (E) Heat inactivation of the 4&#x02010;6 and 7&#x02010;8&#x000a0;hours CM peaks results in sharply decreased <span style="fixed-case">PLVAP</span> upregulation. Western blotting with anti&#x02010;<span style="fixed-case">PLVAP</span> and anti&#x02010;GAPDH</p></div></div></div><p class="p p-last">A more refined analysis in which donor EC were pulsed with PMA, chased in EBM&#x02010;FBS and 1&#x000a0;hours CM &#x0201c;peaks&#x0201d; were collected and incubated with naive acceptor EC for 24&#x000a0;hours (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0003" rid-ob="ob-jcmm13993-fig-0003" co-legend-rid="lgnd_jcmm13993-fig-0003"><span>3</span></a>C), showed that the CM collected between 5 and 6&#x000a0;hours post&#x02010;PMA was able to induce a robust upregulation of PLVAP in naive EC, while other time points had minimal effect (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0003" rid-ob="ob-jcmm13993-fig-0003" co-legend-rid="lgnd_jcmm13993-fig-0003"><span>3</span></a>D). Across multiple experiments carried out with different EC, the highest PLVAP&#x02010;inducing &#x0201c;activity&#x0201d; was always found in the CM peaks collected between 4 and 8&#x000a0;hours. However, 4&#x02010;6&#x000a0;hours CM was usually more potent than 6&#x02010;8&#x000a0;hours CM in upregulating PLVAP.</p></div><div id="jcmm13993-sec-0027" class="sec"><h3 id="jcmm13993-sec-0027title">3.3. PMA up&#x02010;regulates PLVAP via heparin&#x02010;binding and pertussis toxin&#x02010;insensitive factors</h3><p class="p p-first">To determine whether the secreted factor(s) upregulating PLVAP are soluble or membrane bound (exosomes), we fractionated the 4&#x02010;6&#x000a0;h CM into particulate (P) and soluble (S) fractions using ultracentrifugation (see Methods) and tested their ability to up&#x02010;regulate PLVAP in acceptor cells (schematized in Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0004" rid-ob="ob-jcmm13993-fig-0004" co-legend-rid="lgnd_jcmm13993-fig-0004"><span>4</span></a>A, left). Both soluble (S) and particulate (P) fractions had the ability to up&#x02010;regulate PLVAP mRNA at 12&#x000a0;hours, the soluble fraction was more potent (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0004" rid-ob="ob-jcmm13993-fig-0004" co-legend-rid="lgnd_jcmm13993-fig-0004"><span>4</span></a>A, right).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm13993-fig-0004" co-legend-rid="lgnd_jcmm13993-fig-0004"><a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0004/" target="figure" rid-figpopup="jcmm13993-fig-0004" rid-ob="ob-jcmm13993-fig-0004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140004595233248"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g004.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g004.jpg" src="/pmc/articles/PMC6349158/bin/JCMM-23-920-g004.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140004595233248"><a target="object" rel="noopener" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm13993-fig-0004"><div><a class="figpopup" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0004/" target="figure" rid-figpopup="jcmm13993-fig-0004" rid-ob="ob-jcmm13993-fig-0004">Figure 4</a></div><!--caption a7--><div class="caption"><p>Phorbol myristate acetate (<span style="fixed-case">PMA</span>) up&#x02010;regulates plasmalemma vesicle associated protein (<span style="fixed-case">PLVAP</span>) in part via soluble, secreted, heparin&#x02010;binding factors. (A) Schematic of the experimental set&#x02010;up (left) and relative <span style="fixed-case">PLVAP mRNA</span> levels induced by the <span style="fixed-case">CM</span> fractions in acceptor <span style="fixed-case">EC</span> at 12&#x000a0;h after treatment (right). S&#x02014;<span style="fixed-case">CM</span> soluble fraction, P&#x02014;<span style="fixed-case">CM</span> particulate pellet. (<span style="fixed-case">SEM</span>, n&#x000a0;=&#x000a0;3, *<em>P</em>&#x000a0;&#x0003c;&#x000a0;0.05). (B) Schematic of the experimental set&#x02010;up (left) and immunoblotting with anti&#x02010;<span style="fixed-case">PLVAP</span> (the two upper panels, representing different exposure times) and anti&#x02010;<span style="fixed-case">ACTB</span> (lower panel) of acceptor <span style="fixed-case">EC</span> lysates after 24&#x000a0;h treatment with 4&#x02010;6 and 6&#x02010;8&#x000a0;hours CM peaks or the respective <span style="fixed-case">CM</span> depleted on heparin&#x02010;Sepharose (Heparin +). The last two lanes on the right (<span style="fixed-case">PMA</span> 24&#x000a0;h) are duplicates of <span style="fixed-case">PMA</span> treated donor cells used to generate the 4&#x02010;6 and 6&#x02010;8&#x000a0;hours CM peaks. (C) Schematic of the experimental set&#x02010;up (left) and immunoblotting (right) with anti&#x02010;<span style="fixed-case">PLVAP</span> (two upper panels, representing different exposure times) and anti&#x02010;<span style="fixed-case">ACTB</span> (lower panel) antibodies of acceptor <span style="fixed-case">EC</span> lysates after 24&#x000a0;h treatment with 4&#x02010;6 and 6&#x02010;8&#x000a0;hours CM peaks in absence (&#x02212;) or presence (<span style="fixed-case">PT</span>) of pertussis toxin. For comparison, lysates of acceptor <span style="fixed-case">EC</span> treated with <span style="fixed-case">CM</span> peaks depleted with heparin&#x02010;Sepharose (Hep) were included</p></div></div></div><p>To gain insight into the chemical nature of the PLVAP&#x02010;inducing soluble factor(s), we depleted CM peaks (4&#x02010;6 and 6&#x02010;8&#x000a0;hours CM) of heparin&#x02010;binding proteins. As shown in (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0004" rid-ob="ob-jcmm13993-fig-0004" co-legend-rid="lgnd_jcmm13993-fig-0004"><span>4</span></a>B, left), the depletion led to marked decreased in CM ability to induce PLVAP protein in naive acceptor cells (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0004" rid-ob="ob-jcmm13993-fig-0004" co-legend-rid="lgnd_jcmm13993-fig-0004"><span>4</span></a>B, right). Interestingly, the residual activity could not be eliminated even after passages over two sequential heparin columns, (data not shown).</p><p class="p p-last">Endothelial cells produce chemokines, secreted factors that can bind heparin.<a href="#jcmm13993-bib-0045" rid="jcmm13993-bib-0045" class=" ref">45</a> We therefore tested the ability of 4&#x02010;6 and 6&#x02010;8&#x000a0;hours CM peaks to up&#x02010;regulate PLVAP in presence of PT, a general/broad spectrum chemokine receptor inhibitor<a href="#jcmm13993-bib-0046" rid="jcmm13993-bib-0046" class=" ref">46</a>, <a href="#jcmm13993-bib-0047" rid="jcmm13993-bib-0047" class=" ref">47</a> (schematized in Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0004" rid-ob="ob-jcmm13993-fig-0004" co-legend-rid="lgnd_jcmm13993-fig-0004"><span>4</span></a>C, left). Treatment of acceptor EC with PT had no effect on PLVAP protein upregulation by the 4&#x02010;6 and 6&#x02010;8&#x000a0;hours CM peaks (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0004" rid-ob="ob-jcmm13993-fig-0004" co-legend-rid="lgnd_jcmm13993-fig-0004"><span>4</span></a>C, right), ruling out a role for chemokine signalling in this system.</p></div><div id="jcmm13993-sec-0028" class="sec"><h3 id="jcmm13993-sec-0028title">3.4. PMA up&#x02010;regulates PLVAP in part via VEGF/VEGFR2 signalling</h3><p class="p p-first">Phorbol myristate acetate up&#x02010;regulates VEGF&#x02010;A a known heparin&#x02010;binding growth factor<a href="#jcmm13993-bib-0048" rid="jcmm13993-bib-0048" class=" ref">48</a> and its receptors, VEGFR1 and VEGFR2 in HUVEC and HDMVEC,<a href="#jcmm13993-bib-0049" rid="jcmm13993-bib-0049" class=" ref">49</a> making it them as good candidates for PLVAP upregulation by PMA in EC.</p><p>As seen in Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0005" rid-ob="ob-jcmm13993-fig-0005" co-legend-rid="lgnd_jcmm13993-fig-0005"><span>5</span></a>A, a 30&#x02010;minute 50&#x000a0;nmol/L PMA pulse treatment efficiently up&#x02010;regulated VEGF mRNAs (VEGF&#x02010;A&#x02010;121, VEGF&#x02010;A&#x02010;165 and &#x02010;189 isoforms, Figure&#x000a0;<a href="#jcmm13993-sup-0001" rid="jcmm13993-sup-0001" class=" supplementary-material">S1A</a>) in HDMVEC with a peak at 60&#x02010;90&#x000a0;minutes post&#x02010;PMA, accompanied by an increase in VEGF&#x02010;A protein secretion in the medium at 3&#x000a0;hours as detected by a Luminex assay that does not discriminate between the different VEGF&#x02010;A isoforms (data not shown). Increases in VEGFR1 but not VEGFR2 mRNA were also observed in HDMVECn up to 8&#x000a0;hours (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0005" rid-ob="ob-jcmm13993-fig-0005" co-legend-rid="lgnd_jcmm13993-fig-0005"><span>5</span></a>A). However, the VEGFR2 mRNA levels were already substantial in HDMVEC (1510&#x000a0;&#x000b1;&#x000a0;110 SEM mRNA copy numbers/ng total RNA, n&#x000a0;=&#x000a0;22 samples), as determined by absolute quantitative PCR methods.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm13993-fig-0005" co-legend-rid="lgnd_jcmm13993-fig-0005"><a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0005/" target="figure" rid-figpopup="jcmm13993-fig-0005" rid-ob="ob-jcmm13993-fig-0005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140004592397536"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g005.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g005.jpg" src="/pmc/articles/PMC6349158/bin/JCMM-23-920-g005.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140004592397536"><a target="object" rel="noopener" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm13993-fig-0005"><div><a class="figpopup" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0005/" target="figure" rid-figpopup="jcmm13993-fig-0005" rid-ob="ob-jcmm13993-fig-0005">Figure 5</a></div><!--caption a7--><div class="caption"><p>Phorbol myristate acetate (<span style="fixed-case">PMA</span>) up&#x02010;regulates plasmalemma vesicle associated protein (<span style="fixed-case">PLVAP</span>) via vascular endothelial growth factor (<span style="fixed-case">VEGF</span>)/<span style="fixed-case">VEGFR</span>2 signalling. (A) Time course of <span style="fixed-case">PLVAP</span>,<span style="fixed-case"> VEGF</span>&#x02010;A, <span style="fixed-case">VEGFR</span>1 and <span style="fixed-case">VEGFR</span>2 <span style="fixed-case">mRNA</span> changes elicited by a 30&#x000a0;min 50&#x000a0;nmol/L <span style="fixed-case">PMA</span> pulse detected by real time <span style="fixed-case">PCR</span> (<span style="fixed-case">SEM</span>, n&#x000a0;&#x0003e;&#x000a0;6, *<em>P</em>&#x000a0;&#x0003e;&#x000a0;0.05). (B, C) <span style="fixed-case">PMA</span> or <span style="fixed-case">CM</span> is more effective than <span style="fixed-case">VEGF</span>&#x02010;A alone in upregulating <span style="fixed-case">PLVAP</span> protein. Western blotting with anti&#x02010;<span style="fixed-case">PLVAP</span> and anti&#x02010;<span style="fixed-case">GAPDH</span> antibodies of <span style="fixed-case">HDMVEC</span>n total cell lysates at 24&#x000a0;h after treatment with 50&#x000a0;nmol/L <span style="fixed-case">PMA</span> pulse, the noted doses of <span style="fixed-case">VEGF</span>&#x02010;A or <span style="fixed-case">CM</span>. Right panel in (C)&#x02014;densitometric quantitation of the signal ratio of <span style="fixed-case">PLVAP</span>/<span style="fixed-case">GAPDH</span>. (D) Anti&#x02010;<span style="fixed-case">VEGF</span>&#x02010;A antibodies inhibit <span style="fixed-case">PLVAP</span> upregulation by 4&#x02010;6&#x000a0;hours CM. Western blotting with anti&#x02010;<span style="fixed-case">PLVAP</span> and anti&#x02010;<span style="fixed-case">ACTB</span> of acceptor <span style="fixed-case">EC</span> total cell lysates. (E) <span style="fixed-case">VEGF</span>&#x02010;A si<span style="fixed-case">RNA</span> inhibits <span style="fixed-case">PLVAP mRNA</span> upregulation by <span style="fixed-case">PMA</span>. Real time <span style="fixed-case">PCR</span> quantitation of <span style="fixed-case">PLVAP</span> (left) and <span style="fixed-case">VEGF</span>&#x02010;A (right) relative <span style="fixed-case">mRNA</span> levels (&#x00394;&#x00394;Ct method) at 8&#x000a0;h post&#x02010;<span style="fixed-case">PMA</span> or vehicle (&#x0201c;no <span style="fixed-case">PMA</span>&#x0201d;) treatment. &#x0201c;&#x02010;&#x0201d; non&#x02010;transfected control, &#x0201c;mock&#x0201d;&#x02014;mock transfected cells, no si<span style="fixed-case">RNA</span>, &#x0201c;<span style="fixed-case">NC</span>1&#x0201d;&#x02014;negative control si<span style="fixed-case">RNA</span> duplex (<span style="fixed-case">SEM</span>, n&#x000a0;&#x0003e;&#x000a0;3, *<em>P&#x000a0;</em>&#x0003e;<em>&#x000a0;</em>0.05). (F) Combination of <span style="fixed-case">VEGF</span>&#x02010;A and <span style="fixed-case">PMA</span> does not increase <span style="fixed-case">PLVAP</span> levels compared to <span style="fixed-case">PMA</span> alone. Western blotting with anti&#x02010;<span style="fixed-case">PLVAP</span> and anti&#x02010;<span style="fixed-case">GAPDH</span> antibodies of <span style="fixed-case">HDMVEC</span>n total cell lysates treated with 40&#x000a0;ng/mL <span style="fixed-case">VEGF</span>&#x02010;A and the noted concentrations of PMA</p></div></div></div><p>A direct comparison of PLVAP protein levels induced by VEGF&#x02010;A&#x02010;165 (30&#x000a0;minutes or 24&#x000a0;hours treatment) with those induced by PMA or CM (4&#x02010;6 and 6&#x02010;8&#x000a0;hours) demonstrate PMA (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0005" rid-ob="ob-jcmm13993-fig-0005" co-legend-rid="lgnd_jcmm13993-fig-0005"><span>5</span></a>B) or CM (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0005" rid-ob="ob-jcmm13993-fig-0005" co-legend-rid="lgnd_jcmm13993-fig-0005"><span>5</span></a>C) to be much more efficient. VEGF functionality was validated by its effectiveness in inducing VEGFR2 phosphorylation at 2&#x02010;5&#x000a0;minutes post VEGF exposure (data not shown).</p><p>Next, we treated the 4&#x02010;6&#x000a0;hours CM with anti&#x02010;VEGF&#x02010;A antibodies. Doses of 1&#x000a0;&#x003bc;g/mL of anti&#x02010;VEGF&#x02010;A antibody resulted in a detectable inhibition of PLVAP protein upregulation by the 4&#x02010;6&#x000a0;hours CM (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0005" rid-ob="ob-jcmm13993-fig-0005" co-legend-rid="lgnd_jcmm13993-fig-0005"><span>5</span></a>D) in acceptor cells as compared to lower (0.1&#x000a0;&#x003bc;g/mL) anti&#x02010;VEGF&#x02010;A concentrations, irrelevant IgG or non&#x02010;treated CM (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0005" rid-ob="ob-jcmm13993-fig-0005" co-legend-rid="lgnd_jcmm13993-fig-0005"><span>5</span></a>D). Additionally, VEGF&#x02010;A mRNA knockdown by siRNA inhibited PLVAP mRNA upregulation by PMA (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0005" rid-ob="ob-jcmm13993-fig-0005" co-legend-rid="lgnd_jcmm13993-fig-0005"><span>5</span></a>E). However, treatment of EC with up to 40&#x000a0;ng/ml VEGF in addition to PMA does not further increase PLVAP protein levels (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0005" rid-ob="ob-jcmm13993-fig-0005" co-legend-rid="lgnd_jcmm13993-fig-0005"><span>5</span></a>F), suggesting that VEGF&#x02010;A acts downstream of PMA.</p><p>To determine which VEGFR is required for PMA/CM mediated PLVAP upregulation pharmacologic inhibitors with different selectivity for VEGFR1, 2 and 3 (Table&#x000a0;<a href="/pmc/articles/PMC6349158/table/jcmm13993-tbl-0001/" target="table" class="fig-table-link figpopup" rid-figpopup="jcmm13993-tbl-0001" rid-ob="ob-jcmm13993-tbl-0001" co-legend-rid=""><span>1</span></a>) were used. For both PMA (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0006" rid-ob="ob-jcmm13993-fig-0006" co-legend-rid="lgnd_jcmm13993-fig-0006"><span>6</span></a>A) or 4&#x02010;6&#x000a0;hours CM (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0006" rid-ob="ob-jcmm13993-fig-0006" co-legend-rid="lgnd_jcmm13993-fig-0006"><span>6</span></a>B), both VEGFR2 inhibitors cabozantinib and vandetanib decreased PLVAP protein levels at 24&#x000a0;hours after treatment at both 1 and 10&#x000a0;&#x003bc;mol/L, whereas larger VEGFR spectrum Axitinib (Axi) and SAR131676 (SAR) had a detectable effect only at 10&#x000a0;&#x003bc;mol/L. Similar results were obtained for PLVAP mRNA measured at 8&#x000a0;hours post 4&#x02010;6&#x000a0;hours CM treatment (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0006" rid-ob="ob-jcmm13993-fig-0006" co-legend-rid="lgnd_jcmm13993-fig-0006"><span>6</span></a>C). Moreover, cabozantib, the VEGFR2 selective inhibitor, significantly reduced PLVAP mRNA (&#x0003e;50%) at doses as low as 0.01&#x000a0;&#x003bc;mol/L. These data strongly suggest a role for VEGFR2 but not VEGFR1 signalling in PLVAP upregulation by PMA or CM.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm13993-fig-0006" co-legend-rid="lgnd_jcmm13993-fig-0006"><a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/" target="figure" rid-figpopup="jcmm13993-fig-0006" rid-ob="ob-jcmm13993-fig-0006"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140004635565888"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g006.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-23-920-g006.jpg" src="/pmc/articles/PMC6349158/bin/JCMM-23-920-g006.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140004635565888"><a target="object" rel="noopener" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm13993-fig-0006"><div><a class="figpopup" href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/" target="figure" rid-figpopup="jcmm13993-fig-0006" rid-ob="ob-jcmm13993-fig-0006">Figure 6</a></div><!--caption a7--><div class="caption"><p>Phorbol myristate acetate (<span style="fixed-case">PMA</span>) up&#x02010;regulates plasmalemma vesicle associated protein (<span style="fixed-case">PLVAP</span>) in <span style="fixed-case">VEGFR</span>2&#x02010; and <span style="fixed-case">MEK</span>1&#x02010;dependent and p38&#x02010;, <span style="fixed-case">PI</span>3K&#x02010; and Akt&#x02010;independent manner. (A, B) Pharmacological inhibitors of VEGFR2 signalling inhibit PLVAP protein upregulation by PMA (A) or 4&#x02010;6&#x000a0;hours CM (B). Western blotting with anti&#x02010;PLVAP and anti&#x02010;GAPDH of HDMVECn total cell lysates. Densitometric quantitation of the signal ratio of PLVAP/GAPDH is noted under the blot. (C) Pharmacological inhibitors of VEGFR2 signalling inhibit PLVAP mRNA upregulation by 4&#x02010;6&#x000a0;hours CM. Real time PCR quantitation of PLVAP relative mRNA levels 8&#x000a0;h post CM treatment. (SEM, n&#x000a0;=&#x000a0;3, *<em>P</em>&#x000a0;&#x0003e;&#x000a0;0.05). (D) PLVAP upregulation by 4&#x02010;6&#x000a0;hours CM requires de novo protein synthesis. Relative PLVAP mRNA levels as determined by multiplexed quantitative PCR using B2M as housekeeping gene (&#x00394;&#x00394;Ct method). Cells were left untreated (NTC), treated with either 50&#x000a0;nmol/L PMA for 30&#x000a0;min followed by chase with EBM&#x02010;FBS with and without 10&#x000a0;&#x003bc;g/mL CHX (PMA and PMA+CHX) or treated with 4&#x02010;6&#x000a0;hours CM in presence or absence of CHX (CM and CM+CHX). (E&#x02010;G) Real&#x02010;time PCR quantitation of PLVAP relative mRNA levels 12&#x000a0;h post&#x02010;PMA (E) or 4&#x02010;6&#x000a0;hours CM (F, G) treatment in presence of inhibitors MAPK and PI3K/Akt pathways at indicated doses. Inhibitors were as follows: MAPKs:MEK1/2/ERK1/2 (U0126 and PD98059), p38 (SB203580 and SB202190), JNK (tanzisertib, SP600125); PI3K (GDC0941, idelalisib and wortmannin) and Akt (GDC0068). (SEM, n&#x000a0;&#x0003e;&#x000a0;6, *<em>P</em>&#x000a0;&#x0003c;&#x000a0;0.05 vs PMA or CM alone)</p></div></div></div><p class="p p-last">Taken together, the above data demonstrate that while VEGF&#x02010;A/VEGFR2 signalling is important for PLVAP upregulation by PMA, the latter induces the transcription and translation of additional EC factors that are required for efficient PLVAP induction.</p></div><div id="jcmm13993-sec-0029" class="sec"><h3 id="jcmm13993-sec-0029title">3.5. PLVAP upregulation by conditioned medium or VEGF requires further protein synthesis</h3><p class="p p-first">Both CM treated HDMVECn (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0006" rid-ob="ob-jcmm13993-fig-0006" co-legend-rid="lgnd_jcmm13993-fig-0006"><span>6</span></a>D) or 40&#x000a0;ng/mL VEGF&#x02010;A&#x02010;treated HUVEC (not shown) were unable to increase PLVAP mRNA in presence of CHX arguing that further EC protein synthesis is required for PLVAP upregulation.</p><p class="p p-last">To determine if the proteins elicited by CM were secreted, we carried out a CM/CM experiment. First, we established that a 30&#x000a0;minutes 4&#x02010;6&#x000a0;hours CM pulse up&#x02010;regulated PLVAP mRNA in time&#x02010;dependent manner with the increase starting at 4 and peaking at 8&#x02010;12&#x000a0;hours (data not shown) at ~75% of the levels obtained with a 24&#x000a0;hours incubation with same CM. None of the CM/CM peaks was able to significantly up&#x02010;regulate PLVAP mRNA in naive HDMVECn after 24&#x000a0;hours incubation (Figure&#x000a0;<a href="#jcmm13993-sup-0001" rid="jcmm13993-sup-0001" class=" supplementary-material">S1B</a>), demonstrating that while protein synthesis is required for PLVAP upregulation by the 4&#x02010;6 CM, it most likely involves the synthesis of cytoplasmic signalling molecules/transcription regulators rather than secreted/shed molecules.</p></div><div id="jcmm13993-sec-0030" class="sec sec-last"><h3 id="jcmm13993-sec-0030title">3.6. PMA up&#x02010;regulates PLVAP in MEK1/2&#x02010;dependent and p38&#x02010;, JNK&#x02010; and PI3K/Akt&#x02010;independent manner</h3><p class="p p-first">We next explored the role of signalling pathways downstream of VEGFR2 using pharmacological inhibition (Table&#x000a0;<a href="/pmc/articles/PMC6349158/table/jcmm13993-tbl-0001/" target="table" class="fig-table-link figpopup" rid-figpopup="jcmm13993-tbl-0001" rid-ob="ob-jcmm13993-tbl-0001" co-legend-rid=""><span>1</span></a>). The ability of both PMA (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0006" rid-ob="ob-jcmm13993-fig-0006" co-legend-rid="lgnd_jcmm13993-fig-0006"><span>6</span></a>E) and 4&#x02010;6&#x000a0;hours CM (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0006" rid-ob="ob-jcmm13993-fig-0006" co-legend-rid="lgnd_jcmm13993-fig-0006"><span>6</span></a>F,H) to up&#x02010;regulate PLVAP mRNA was inhibited by the MEK1/2 inhibitors U0126 and PD98059 in dose&#x02010;dependent manner. No changes in PLVAP upregulation were observed in the presence of p38 MAPK inhibitors such as SB203580 or SB202190, or JNK inhibitors SP600125 and tanzisertib (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0006" rid-ob="ob-jcmm13993-fig-0006" co-legend-rid="lgnd_jcmm13993-fig-0006"><span>6</span></a>E&#x02010;F,H).</p><p>Furthermore, PI3K signalling inhibition with both pictilisib and idelalisib had no impact on PLVAP upregulation by either PMA (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0006" rid-ob="ob-jcmm13993-fig-0006" co-legend-rid="lgnd_jcmm13993-fig-0006"><span>6</span></a>E) or 4&#x02010;6&#x000a0;hours CM (Figure&#x000a0;<a href="/pmc/articles/PMC6349158/figure/jcmm13993-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm13993-fig-0006" rid-ob="ob-jcmm13993-fig-0006" co-legend-rid="lgnd_jcmm13993-fig-0006"><span>6</span></a>F,G). However, wortmannin, another potent pan&#x02010;PI3K inhibitor reduces PLVAP mRNA and protein upregulation but only at the larger dose of 10&#x000a0;&#x003bc;mol/L, which may represent an off&#x02010;target inhibition of other kinases. Finally, consistent with lack of impact of PI3K inhibition, signalling downstream of PMA or CM does not require Akt, a main PI3K downstream effector, as shown by the lack of inhibition of PLVAP upregulation by Ipatasertib doses of 1&#x02010;10&#x000a0;&#x003bc;mol/L.</p><p class="p p-last">In each experiment, the effectiveness of each inhibitor was confirmed by Western blotting on their ability to block or activate specific phosphorylation events within known signalling pathways in response to PMA at 15, 30 and 60&#x000a0;minutes in HDMVECn: U0126&#x02014;Erk1/2 phosphorylation; SB203580 and SB202190&#x02014;p38 phosphorylation; pictilisib, idelalisib, wortmannin and GDC0068&#x02014;Akt1 phosphorylation (data not shown). Thus, while the upregulation of PLVAP by PMA requires VEGF, there is a clear requirement for MEK1/ERK1/2 signalling whereas p38, JNK, PI3K&#x003b1;/&#x003b4;/&#x003b3; and Akt1&#x02010;3 are not required in this system.</p></div></div><div id="jcmm13993-sec-0031" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm13993-sec-0031title">4. DISCUSSION</h2><p class="p p-first">Research on endothelial diaphragms has been hampered by a lack of in&#x000a0;vitro model systems that faithfully replicate the in&#x000a0;situ biogenetic signalling. With this long&#x02010;term goal in mind, we began characterizing the signalling events during the DAG agonist (PMA) induction of PLVAP and diaphragms in primary EC. This system offers the advantage of allowing the study of PLVAP induction and formation of fenestrae.</p><p>Our data show that PLVAP mRNA upregulation by PMA is dependent on de novo protein synthesis. These newly synthesized proteins could be secreted proteins, cytoplasmic signalling molecules and/or regulators of transcription. By optimizing conditions for CM transfer experiments, we showed that neosynthesis of secreted molecules are required for PLVAP upregulation. A 30&#x000a0;minute pulse treatment with PMA up&#x02010;regulated PLVAP mRNA as early as 2&#x000a0;hours with a peak induction between 8 and 12&#x000a0;hours after treatment in dose&#x02010;dependent manner and was similarly effective in upregulating PLVAP protein as 24&#x000a0;hours at the same dose. CM experiments showed the presence within 4&#x02010;8&#x000a0;hours after PMA treatment of newly synthesized, heat labile proteins that are able to induce PLVAP mRNA and protein in PMA naive EC. The CHX experiments and the relative lack of PLVAP&#x02010;inducing &#x0201c;activity&#x0201d; in the CM collected 1&#x000a0;hour after PMA treatment strongly argue that transcription and protein synthesis is required to generate the factor(s) responsible for PLVAP upregulation. It also ruled out the secretagogue effect of PMA<a href="#jcmm13993-bib-0050" rid="jcmm13993-bib-0050" class=" ref">50</a> or leakage of PMA from donor cells into the CM.</p><p>Conditioned medium fractionation by ultracentrifugation showed that most of the PLVAP&#x02010;inducing factors are soluble proteins. We have found, however, that the particulate fraction of the CM (expected to contain exosomes) is also able to induce PLVAP upregulation albeit at lower levels. Further proteomic experiments should elucidate whether the PLVAP&#x02010;inducing proteins in the soluble and particulate fractions of the CM are the same or not.</p><p>Heparin depletion experiments demonstrated that multiple factors in the CM may be involved in PLVAP upregulation by PMA with most but not all of these factors bind heparin.</p><p>We were able to rule out a role for chemokines, known to bind heparin, as PT was unable to inhibit PLVAP upregulation by the 4&#x02010;6 and 6&#x02010;8&#x000a0;hours CM at a dose widely accepted in the literature as effective.</p><p>Among the PMA&#x02010;induced growth factors known to bind heparin, a survey of the literature yielded VEGF&#x02010;A as a candidate. VEGF&#x02010;A signalling via VEGFR2 up&#x02010;regulates PLVAP in single donor HUVEC.<a href="#jcmm13993-bib-0030" rid="jcmm13993-bib-0030" class=" ref">30</a> While we confirmed the rapid upregulation by PMA of VEGF&#x02010;A mRNA peaking at 60&#x02010;90&#x000a0;minutes after treatment, no significant VEGFR2 mRNA increase was observed in HDMVECn up to 24&#x000a0;hours after treatment. However, HDMVECn already express substantial levels of VEGFR2. Additionally, PMA up&#x02010;regulated VEGFR1 (Flt 1) as early as 2&#x000a0;hours after treatment with a peak at 4&#x02010;8&#x000a0;hours, although the significance of this increase to the overall economy of VEGF&#x02010;A signalling in this system is unclear.</p><p>While VEGF&#x02010;A165 elicited low levels of PLVAP mRNA and protein in HDMVECn, PMA or post&#x02010;PMA CM has a &#x0003e;10&#x02010;fold greater ability to up&#x02010;regulate PLVAP. Anti&#x02010;VEGF&#x02010;A antibody blockade and VEGF&#x02010;A mRNA knockdown with siRNA partially inhibits the ability of PMA or post&#x02010;PMA CM to up&#x02010;regulate PLVAP, arguing that VEGF plays a role in PLVAP upregulation. Addition of exogenous 40&#x000a0;ng/ml VEGF (a dose widely accepted in the literature as activating) to PMA or CM did not increase PLVAP transcription at different time points and protein levels at 24&#x000a0;hours, suggesting that: (a) VEGF&#x02010;A signalling is an early step within a sequential signalling pathway leading from PMA to PLVAP upregulation; or, (b) VEGF&#x02010;A signalling synergizes with/is additive to other signalling factors induced by PMA and by the time these factors are up&#x02010;regulated, VEGF&#x02010;A levels are already saturating, hence the lack of synergistic or additive effect between VEGF&#x02010;A and PMA or CM. While not particularly enhancing either scenario, translation arrest experiments demonstrate that both VEGF&#x02010;A and CM require downstream de novo protein synthesis to be able to up&#x02010;regulate PLVAP. Finally, VEGFR2 is thought to transduce all known effects of VEGF&#x02010;A<a href="#jcmm13993-bib-0051" rid="jcmm13993-bib-0051" class=" ref">51</a> and was implicated in VEGF upregulation of PLVAP.<a href="#jcmm13993-bib-0030" rid="jcmm13993-bib-0030" class=" ref">30</a> The pharmacological inhibition results strongly support a role for VEGFR2 in PLVAP upregulation by PMA and CM. The rather sizeable effects of VEGF&#x02010;A knockdown and VEGFR2 inhibition on PLVAP transcription lend support to a model in which VEGF/VEGFR2 signalling is an early event in a series of signalling events leading to PLVAP upregulation or a necessary synergistic partner to other factors. Additionally, our results may also implicate VEGFR3 (Flt 4) in PLVAP upregulation by PMA and 4&#x02010;6&#x000a0;hours CM and this relationship will be further explored in future work.</p><p>Given the role of VEGF/VEGFR2 signalling in PLVAP upregulation by PMA, there is apparent conflict between earlier data showing that PMA upregulation of PLVAP was MEK1&#x02010;dependent<a href="#jcmm13993-bib-0016" rid="jcmm13993-bib-0016" class=" ref">16</a> whereas PD98059 (a MEK1 inhibitor) had little effect on PLVAP mRNA and protein upregulation at 48&#x000a0;hours post VEGF&#x02010;A treatment.<a href="#jcmm13993-bib-0030" rid="jcmm13993-bib-0030" class=" ref">30</a> Using the same two inhibitors (U0126 and PD98059) we confirmed our earlier findings that PMA up&#x02010;regulates PLVAP in MEK1/ERK1/2&#x02014;dependent manner and we further show the same to be true for PLVAP upregulation by the post&#x02010;PMA CM. A simple explanation of this discrepancy would be that the other secreted factors required for PLVAP upregulation by PMA signal through MEK1/ERK1/2 pathway. Notwithstanding the cell culture differences between our work and earlier reports regarding cell starvation medium and length, cell type, composition of the stimulation medium and especially length of stimulation, these differences could be technical (ie PD98059 requires higher doses for MEK 1 inhibition and is rather unstable) and the case is that VEGF&#x02010;A does induce PLVAP upregulation via ERK1/2. VEGF&#x02010;A is known to activate the Raf/MEK/ERK pathway in human ECs (reviewed in<a href="#jcmm13993-bib-0051" rid="jcmm13993-bib-0051" class=" ref">51</a>). Unfortunately, due to the rather inefficient upregulation of PLVAP by VEGF&#x02010;A in our cells we were unable to reliably investigate the effect of these inhibitors on PLVAP upregulation by VEGF&#x02010;A. In any case, the Erk1/2 downstream effectors involved in PLVAP upregulation would be interesting to elucidate in the future.</p><p>Plasmalemma vesicle associated protein has also been shown to be regulated by VEGF&#x02010;A/VEGFR2 signalling in p38 MAPK&#x02010;dependent manner although no known downstream targets of p38 were found to be involved.<a href="#jcmm13993-bib-0030" rid="jcmm13993-bib-0030" class=" ref">30</a> Quantitative mRNA analysis (data not shown) demonstrated that HDMVECn express all the p38 isoforms (p38&#x003b1;/MAPK14, p38&#x003b2;/MAPK11, p38&#x003b3;/MAPK12, p38&#x003b4;/MAPK13), with p38&#x003b3;/MAPK12 being the least abundant. Nevertheless, our results show no inhibition of PLVAP mRNA upregulation at 8 and 24&#x000a0;hours post either PMA or CM treatment by two widely used pan p38 inhibitors, despite our demonstration that the same doses of these inhibitors block p38 MAPK phosphorylation in response to PMA. Both inhibitors are active against all p38 isoforms with IC50 in the nanomolar range and the doses used were 2&#x02010;3 orders of magnitude larger. However, while our data do not support a role for p38 signalling in PMA or CM induced PLVAP upregulation, these results are puzzling given the role of VEGF/VEGFR2 signalling in this process.</p><p>Others have suggested that VEGF&#x02010;A regulates PLVAP expression in PI3 kinase&#x02010;dependent manner.<a href="#jcmm13993-bib-0030" rid="jcmm13993-bib-0030" class=" ref">30</a> HDMVEC express all four isoforms of p110 (&#x003b1;/PIK3CA, &#x003b2;/PIK3CB, &#x003b3;/PIK3CG and &#x003b4;/PIK3CD) and the respective p85/p55/p150 regulatory subunits (PIK3R1&#x02010;4). Using novel and more selective PI3K pharmacological inhibitors that are in clinical trials such as pictisilib (highly selective for PI3K&#x003b1;/&#x003b4; and 11&#x02010;25 fold lower selectivity on PI3K&#x003b2;/&#x003b3;) and idelalisib (selective for PI3K&#x003b3;&#x0003e;&#x003b4;), we show that PI3K inhibition does not inhibit PLVAP upregulation by PMA or CM. Accordingly, the inhibition of Akt1&#x02010;3, a major downstream target of PI3K, does not impact PLVAP upregulation. To note, wortmannin, a pan PI3K inhibitor, is partially effective at the larger concentration of 10&#x000a0;&#x003bc;mol/L either suggesting off&#x02010;target effects or a role for p110&#x003b2;, which is not covered as well by the other inhibitors used. However, the latter is less likely as the dose of pictisilib we used is several orders of magnitude larger than the IC50 for p110&#x003b2;.</p><p class="p p-last">In summary, we find that PLVAP upregulation by PMA requires de novo synthesis of multiple secreted proteins that act in an autocrine manner. One of the soluble factors involved is VEGF&#x02010;A acting through VEGFR2. The signalling is dependent on MEK1/ERK1/2 and independent of p38, JNK, PI3K and Akt1&#x02010;3. Further transcriptomic and proteomic studies should identify the factors (or combinations thereof) contributing to PLVAP regulation.</p></div><div id="jcmm13993-sec-0032" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm13993-sec-0032title">ACKNOWLEDGEMENTS</h2><p class="p p-first-last">This work was supported from National Institutes of Health grant 1R01GM120592 and American Heart Association grant 16GRNT27260362 to RVS. NCCC DartLab and Microscopy Shared Resources are supported by NCI Cancer Center Support Grant 5P30CA023108&#x02010;37. We would like to thank Yan Xu for technical assistance in early stages of this project, N. Shworak for advice and C. Carriere for critically reading the manuscript.</p></div><div id="jcmm13993-sec-0033" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm13993-sec-0033title">CONFLICT OF INTEREST</h2><p class="p p-first-last">The authors confirm that there are no conflicts of interest.</p></div><div id="jcmm13993-sec-0034" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm13993-sec-0034title">AUTHOR CONTRIBUTIONS</h2><p class="p p-first-last">BJH, DT and RVS performed and designed experiments. BJH and RVS wrote the paper.</p></div><div id="sec-a.n.h" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sec-a.n.htitle">Supporting information</h2><!--/article/body/sec/--><div class="sec suppmat" id="jcmm13993-sup-0001"><p>&#x000a0;</p><div class="sup-box half_rhythm" id="media-a.n.h.b.b"><a href="/pmc/articles/PMC6349158/bin/JCMM-23-920-s001.eps" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(7.3M, eps)</sup></div></div></div><div id="notes-a.m.c" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.m.ctitle">Notes</h2><p>
<span class="mixed-citation" id="jcmm13993-cit-1001">
Hamilton BJ, Tse D, Stan RV. <span class="ref-title">Phorbol esters induce PLVAP expression via VEGF and additional secreted molecules in MEK1&#x02010;dependent and p38, JNK and PI3K/Akt&#x02010;independent manner</span>. <span class="ref-journal">J Cell Mol Med</span>. 2019;<span class="ref-vol">23</span>:920&#x02013;933. 10.1111/jcmm.13993
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6349158/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30394679" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fjcmm.13993" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Mol+Med&amp;title=Phorbol+esters+induce+PLVAP+expression+via+VEGF+and+additional+secreted+molecules+in+MEK1&#x02010;dependent+and+p38,+JNK+and+PI3K/Akt&#x02010;independent+manner&amp;volume=23&amp;publication_year=2019&amp;pages=920-933&amp;doi=10.1111/jcmm.13993&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span>
</p></div><div id="jcmm13993-bibl-0001" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm13993-bibl-0001title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0001">1. <span class="mixed-citation" id="jcmm13993-cit-0001">
Stan RV. <span class="ref-title">Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis</span>. <span class="ref-journal">J Cell Mol Med</span>. 2007;<span class="ref-vol">11</span>:621&#x02010;643. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3823246/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17760829" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Mol+Med&amp;title=Endothelial+stomatal+and+fenestral+diaphragms+in+normal+vessels+and+angiogenesis&amp;volume=11&amp;publication_year=2007&amp;pages=621-643&amp;pmid=17760829&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0002">2. <span class="mixed-citation" id="jcmm13993-cit-0002">
Tse D, Stan RV. <span class="ref-title">Morphological heterogeneity of endothelium</span>. <span class="ref-journal">Semin Thromb Hemost</span>. 2010;<span class="ref-vol">36</span>:236&#x02010;245. [<a href="https://pubmed.ncbi.nlm.nih.gov/20490976" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Thromb+Hemost&amp;title=Morphological+heterogeneity+of+endothelium&amp;volume=36&amp;publication_year=2010&amp;pages=236-245&amp;pmid=20490976&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0003">3. <span class="mixed-citation" id="jcmm13993-cit-0003">
Stan RV, Tse D, Deharvengt SJ, et&#x000a0;al. <span class="ref-title">The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition</span>. <span class="ref-journal">Dev Cell</span>. 2012;<span class="ref-vol">23</span>:1203&#x02010;1218. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3525343/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23237953" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dev+Cell&amp;title=The+diaphragms+of+fenestrated+endothelia:+gatekeepers+of+vascular+permeability+and+blood+composition&amp;volume=23&amp;publication_year=2012&amp;pages=1203-1218&amp;pmid=23237953&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0004">4. <span class="mixed-citation" id="jcmm13993-cit-0004">
Herrnberger L, Seitz R, Kuespert S, et&#x000a0;al. <span class="ref-title">Lack of endothelial diaphragms in fenestrae and caveolae of mutant Plvap&#x02010;deficient mice</span>. <span class="ref-journal">Histochem Cell Biol</span>. 2012;<span class="ref-vol">138</span>:709&#x02010;724. [<a href="https://pubmed.ncbi.nlm.nih.gov/22782339" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Histochem+Cell+Biol&amp;title=Lack+of+endothelial+diaphragms+in+fenestrae+and+caveolae+of+mutant+Plvap&#x02010;deficient+mice&amp;volume=138&amp;publication_year=2012&amp;pages=709-724&amp;pmid=22782339&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0005">5. <span class="mixed-citation" id="jcmm13993-cit-0005">
Rantakari P, Auvinen K, Jappinen N, et&#x000a0;al. <span class="ref-title">The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes</span>. <span class="ref-journal">Nat Immunol</span>. 2015;<span class="ref-vol">16</span>:386&#x02010;396. [<a href="https://pubmed.ncbi.nlm.nih.gov/25665101" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Immunol&amp;title=The+endothelial+protein+PLVAP+in+lymphatics+controls+the+entry+of+lymphocytes+and+antigens+into+lymph+nodes&amp;volume=16&amp;publication_year=2015&amp;pages=386-396&amp;pmid=25665101&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0006">6. <span class="mixed-citation" id="jcmm13993-cit-0006">
Elkadri A, Thoeni C, Deharvengt SJ, et&#x000a0;al. <span class="ref-title">Mutations in plasmalemma vesicle associated protein result in sieving protein&#x02010;losing enteropathy characterized by hypoproteinemia, hypoalbuminemia, and hypertriglyceridemia</span>. <span class="ref-journal">Cell Mol Gastroenterol Hepatol</span>. 2015;<span class="ref-vol">1</span>:381&#x02010;94 e7. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4507283/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26207260" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Mol+Gastroenterol+Hepatol&amp;title=Mutations+in+plasmalemma+vesicle+associated+protein+result+in+sieving+protein&#x02010;losing+enteropathy+characterized+by+hypoproteinemia,+hypoalbuminemia,+and+hypertriglyceridemia&amp;volume=1&amp;publication_year=2015&amp;pages=381-94+e7&amp;pmid=26207260&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0007">7. <span class="mixed-citation" id="jcmm13993-cit-0007">
Broekaert IJ, Becker K, Gottschalk I, et&#x000a0;al. <span class="ref-title">Mutations in plasmalemma vesicle&#x02010;associated protein cause severe syndromic protein&#x02010;losing enteropathy</span>. <span class="ref-journal">J Med Genet</span>
2018;<span class="ref-vol">55</span>:637&#x02010;640. [<a href="https://pubmed.ncbi.nlm.nih.gov/29661969" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Genet&amp;title=Mutations+in+plasmalemma+vesicle&#x02010;associated+protein+cause+severe+syndromic+protein&#x02010;losing+enteropathy&amp;volume=55&amp;publication_year=2018&amp;pages=637-640&amp;pmid=29661969&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0008">8. <span class="mixed-citation" id="jcmm13993-cit-0008">
Kurolap A, Eshach&#x02010;Adiv O, Gonzaga&#x02010;Jauregui C, et&#x000a0;al. <span class="ref-title">Establishing the role of PLVAP in protein&#x02010;losing enteropathy: a homozygous missense variant leads to an attenuated phenotype</span>. <span class="ref-journal">J Med Genet</span>
2018. 
 10.1136/jmedgenet-2018-105299. [<a href="https://pubmed.ncbi.nlm.nih.gov/29875123" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1136%2Fjmedgenet-2018-105299" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Genet&amp;title=Establishing+the+role+of+PLVAP+in+protein&#x02010;losing+enteropathy:+a+homozygous+missense+variant+leads+to+an+attenuated+phenotype&amp;publication_year=2018&amp;doi=10.1136/jmedgenet-2018-105299&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0009">9. <span class="mixed-citation" id="jcmm13993-cit-0009">
Keuschnigg J, Henttinen T, Auvinen K, et&#x000a0;al. <span class="ref-title">The prototype endothelial marker PAL&#x02010;E is a leukocyte trafficking molecule</span>. <span class="ref-journal">Blood</span>. 2009;<span class="ref-vol">114</span>:478&#x02010;484. [<a href="https://pubmed.ncbi.nlm.nih.gov/19420356" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=The+prototype+endothelial+marker+PAL&#x02010;E+is+a+leukocyte+trafficking+molecule&amp;volume=114&amp;publication_year=2009&amp;pages=478-484&amp;pmid=19420356&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0010">10. <span class="mixed-citation" id="jcmm13993-cit-0010">
Elgueta R, Tse D, Deharvengt SJ, et&#x000a0;al. <span class="ref-title">Endothelial plasmalemma vesicle&#x02010;associated protein regulates the homeostasis of splenic immature B cells and B&#x02010;1 B cells</span>. <span class="ref-journal">J Immunol</span>. 2016;<span class="ref-vol">197</span>:3970&#x02010;3981. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5120863/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27742829" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Endothelial+plasmalemma+vesicle&#x02010;associated+protein+regulates+the+homeostasis+of+splenic+immature+B+cells+and+B&#x02010;1+B+cells&amp;volume=197&amp;publication_year=2016&amp;pages=3970-3981&amp;pmid=27742829&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0011">11. <span class="mixed-citation" id="jcmm13993-cit-0011">
Rantakari P, Jappinen N, Lokka E, et&#x000a0;al. <span class="ref-title">Fetal liver endothelium regulates the seeding of tissue&#x02010;resident macrophages</span>. <span class="ref-journal">Nature</span>. 2016;<span class="ref-vol">538</span>:392&#x02010;396. [<a href="https://pubmed.ncbi.nlm.nih.gov/27732581" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Fetal+liver+endothelium+regulates+the+seeding+of+tissue&#x02010;resident+macrophages&amp;volume=538&amp;publication_year=2016&amp;pages=392-396&amp;pmid=27732581&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0012">12. <span class="mixed-citation" id="jcmm13993-cit-0012">
Stan RV, Arden KC, Palade GE. <span class="ref-title">cDNA and protein sequence, genomic organization, and analysis of cis regulatory elements of mouse and human PLVAP genes</span>. <span class="ref-journal">Genomics</span>. 2001;<span class="ref-vol">72</span>:304&#x02010;313. [<a href="https://pubmed.ncbi.nlm.nih.gov/11401446" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genomics&amp;title=cDNA+and+protein+sequence,+genomic+organization,+and+analysis+of+cis+regulatory+elements+of+mouse+and+human+PLVAP+genes&amp;volume=72&amp;publication_year=2001&amp;pages=304-313&amp;pmid=11401446&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0013">13. <span class="mixed-citation" id="jcmm13993-cit-0013">
Stan R, Ghitescu L, Jacobson B, et&#x000a0;al. <span class="ref-title">Purification and cloning of PV&#x02010;1, a novel caveolar protein of the rat microvasculature</span>. <span class="ref-journal">Mol Biol Cell</span>. 1998;<span class="ref-vol">9</span>:96A&#x02010;A. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Biol+Cell&amp;title=Purification+and+cloning+of+PV&#x02010;1,+a+novel+caveolar+protein+of+the+rat+microvasculature&amp;volume=9&amp;publication_year=1998&amp;pages=96A&#x02010;A&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0014">14. <span class="mixed-citation" id="jcmm13993-cit-0014">
Stan RV, Kubitza M, Palade GE. <span class="ref-title">PV&#x02010;1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia</span>. <span class="ref-journal">Proc Natl Acad Sci U S A</span>. 1999;<span class="ref-vol">96</span>:13203&#x02010;13207. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC23925/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10557298" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=PV&#x02010;1+is+a+component+of+the+fenestral+and+stomatal+diaphragms+in+fenestrated+endothelia&amp;volume=96&amp;publication_year=1999&amp;pages=13203-13207&amp;pmid=10557298&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0015">15. <span class="mixed-citation" id="jcmm13993-cit-0015">
Tkachenko E, Tse D, Sideleva O, et&#x000a0;al. <span class="ref-title">Caveolae, fenestrae and transendothelial channels retain PV1 on the surface of endothelial cells</span>. <span class="ref-journal">PLoS ONE</span>. 2012;<span class="ref-vol">7</span>:e32655. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3293851/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22403691" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Caveolae,+fenestrae+and+transendothelial+channels+retain+PV1+on+the+surface+of+endothelial+cells&amp;volume=7&amp;publication_year=2012&amp;pages=e32655&amp;pmid=22403691&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0016">16. <span class="mixed-citation" id="jcmm13993-cit-0016">
Stan RV, Tkachenko E, Niesman IR. <span class="ref-title">PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms</span>. <span class="ref-journal">Mol Biol Cell</span>. 2004;<span class="ref-vol">15</span>:3615&#x02010;3630. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC491823/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15155804" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Biol+Cell&amp;title=PV1+is+a+key+structural+component+for+the+formation+of+the+stomatal+and+fenestral+diaphragms&amp;volume=15&amp;publication_year=2004&amp;pages=3615-3630&amp;pmid=15155804&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0017">17. <span class="mixed-citation" id="jcmm13993-cit-0017">
Ioannidou S, Deinhardt K, Miotla J, et&#x000a0;al. <span class="ref-title">An in&#x000a0;vitro assay reveals a role for the diaphragm protein PV&#x02010;1 in endothelial fenestra morphogenesis</span>. <span class="ref-journal">Proc Natl Acad Sci U S A</span>. 2006;<span class="ref-vol">103</span>:16770&#x02010;16775. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1636530/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17075074" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=An+in&#x000a0;vitro+assay+reveals+a+role+for+the+diaphragm+protein+PV&#x02010;1+in+endothelial+fenestra+morphogenesis&amp;volume=103&amp;publication_year=2006&amp;pages=16770-16775&amp;pmid=17075074&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0018">18. <span class="mixed-citation" id="jcmm13993-cit-0018">
Lombardi T, Montesano R, Orci L. <span class="ref-title">Phorbol ester induces diaphragmed fenestrae in large vessel endothelium in&#x000a0;vitro</span>. <span class="ref-journal">Eur J Cell Biol</span>. 1987;<span class="ref-vol">44</span>:86&#x02010;89. [<a href="https://pubmed.ncbi.nlm.nih.gov/3622535" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Cell+Biol&amp;title=Phorbol+ester+induces+diaphragmed+fenestrae+in+large+vessel+endothelium+in&#x000a0;vitro&amp;volume=44&amp;publication_year=1987&amp;pages=86-89&amp;pmid=3622535&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0019">19. <span class="mixed-citation" id="jcmm13993-cit-0019">
Loesberg C, Gonsalves MD, Zandbergen J, et&#x000a0;al. <span class="ref-title">The effect of calcium on the secretion of factor VIII&#x02010;related antigen by cultured human endothelial cells</span>. <span class="ref-journal">Biochim Biophys Acta</span>. 1983;<span class="ref-vol">763</span>:160&#x02010;168. [<a href="https://pubmed.ncbi.nlm.nih.gov/6311284" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;title=The+effect+of+calcium+on+the+secretion+of+factor+VIII&#x02010;related+antigen+by+cultured+human+endothelial+cells&amp;volume=763&amp;publication_year=1983&amp;pages=160-168&amp;pmid=6311284&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0020">20. <span class="mixed-citation" id="jcmm13993-cit-0020">
Roberts WG, Palade GE. <span class="ref-title">Neovasculature induced by vascular endothelial growth factor is fenestrated</span>. <span class="ref-journal">Cancer Res</span>. 1997;<span class="ref-vol">57</span>:765&#x02010;772. [<a href="https://pubmed.ncbi.nlm.nih.gov/9044858" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Neovasculature+induced+by+vascular+endothelial+growth+factor+is+fenestrated&amp;volume=57&amp;publication_year=1997&amp;pages=765-772&amp;pmid=9044858&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0021">21. <span class="mixed-citation" id="jcmm13993-cit-0021">
Roberts WG, Palade GE. <span class="ref-title">Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor</span>. <span class="ref-journal">J Cell Sci</span>. 1995;<span class="ref-vol">108</span>(<span class="ref-iss">Pt 6</span>):2369&#x02010;2379. [<a href="https://pubmed.ncbi.nlm.nih.gov/7673356" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Sci&amp;title=Increased+microvascular+permeability+and+endothelial+fenestration+induced+by+vascular+endothelial+growth+factor&amp;volume=108&amp;issue=Pt+6&amp;publication_year=1995&amp;pages=2369-2379&amp;pmid=7673356&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0022">22. <span class="mixed-citation" id="jcmm13993-cit-0022">
Eriksson A, Cao R, Roy J, et&#x000a0;al. <span class="ref-title">Small GTP&#x02010;binding protein Rac is an essential mediator of vascular endothelial growth factor&#x02010;induced endothelial fenestrations and vascular permeability</span>. <span class="ref-journal">Circulation</span>. 2003;<span class="ref-vol">107</span>:1532&#x02010;1538. [<a href="https://pubmed.ncbi.nlm.nih.gov/12654612" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Small+GTP&#x02010;binding+protein+Rac+is+an+essential+mediator+of+vascular+endothelial+growth+factor&#x02010;induced+endothelial+fenestrations+and+vascular+permeability&amp;volume=107&amp;publication_year=2003&amp;pages=1532-1538&amp;pmid=12654612&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0023">23. <span class="mixed-citation" id="jcmm13993-cit-0023">
Cao R, Eriksson A, Kubo H, et&#x000a0;al. <span class="ref-title">Comparative evaluation of FGF&#x02010;2&#x02010;, VEGF&#x02010;A&#x02010;, and VEGF&#x02010;C&#x02010;induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability</span>. <span class="ref-journal">Circ Res</span>. 2004;<span class="ref-vol">94</span>:664&#x02010;670. [<a href="https://pubmed.ncbi.nlm.nih.gov/14739162" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circ+Res&amp;title=Comparative+evaluation+of+FGF&#x02010;2&#x02010;,+VEGF&#x02010;A&#x02010;,+and+VEGF&#x02010;C&#x02010;induced+angiogenesis,+lymphangiogenesis,+vascular+fenestrations,+and+permeability&amp;volume=94&amp;publication_year=2004&amp;pages=664-670&amp;pmid=14739162&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0024">24. <span class="mixed-citation" id="jcmm13993-cit-0024">
Cao R, Brakenhielm E, Wahlestedt C, et&#x000a0;al. <span class="ref-title">Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF&#x02010;2 and VEGF</span>. <span class="ref-journal">Proc Natl Acad Sci U S A</span>. 2001;<span class="ref-vol">98</span>:6390&#x02010;6395. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC33478/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11344271" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Leptin+induces+vascular+permeability+and+synergistically+stimulates+angiogenesis+with+FGF&#x02010;2+and+VEGF&amp;volume=98&amp;publication_year=2001&amp;pages=6390-6395&amp;pmid=11344271&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0025">25. <span class="mixed-citation" id="jcmm13993-cit-0025">
Nagy JA, Feng D, Vasile E, et&#x000a0;al. <span class="ref-title">Permeability properties of tumor surrogate blood vessels induced by VEGF&#x02010;A</span>. <span class="ref-journal">Lab Invest</span>. 2006;<span class="ref-vol">86</span>:767&#x02010;780. [<a href="https://pubmed.ncbi.nlm.nih.gov/16732297" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lab+Invest&amp;title=Permeability+properties+of+tumor+surrogate+blood+vessels+induced+by+VEGF&#x02010;A&amp;volume=86&amp;publication_year=2006&amp;pages=767-780&amp;pmid=16732297&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0026">26. <span class="mixed-citation" id="jcmm13993-cit-0026">
Carpenter B, Lin Y, Stoll S, et&#x000a0;al. <span class="ref-title">VEGF is crucial for the hepatic vascular development required for lipoprotein uptake</span>. <span class="ref-journal">Development</span>. 2005;<span class="ref-vol">132</span>:3293&#x02010;3303. [<a href="https://pubmed.ncbi.nlm.nih.gov/15944181" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Development&amp;title=VEGF+is+crucial+for+the+hepatic+vascular+development+required+for+lipoprotein+uptake&amp;volume=132&amp;publication_year=2005&amp;pages=3293-3303&amp;pmid=15944181&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0027">27. <span class="mixed-citation" id="jcmm13993-cit-0027">
Eremina V, Sood M, Haigh J, et&#x000a0;al. <span class="ref-title">Glomerular&#x02010;specific alterations of VEGF&#x02010;A expression lead to distinct congenital and acquired renal diseases</span>. <span class="ref-journal">J Clin Invest</span>. 2003;<span class="ref-vol">111</span>:707&#x02010;716. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC151905/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12618525" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Glomerular&#x02010;specific+alterations+of+VEGF&#x02010;A+expression+lead+to+distinct+congenital+and+acquired+renal+diseases&amp;volume=111&amp;publication_year=2003&amp;pages=707-716&amp;pmid=12618525&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0028">28. <span class="mixed-citation" id="jcmm13993-cit-0028">
Lammert E, Gu G, McLaughlin M, et&#x000a0;al. <span class="ref-title">Role of VEGF&#x02010;A in vascularization of pancreatic islets</span>. <span class="ref-journal">Curr Biol</span>. 2003;<span class="ref-vol">13</span>:1070&#x02010;1074. [<a href="https://pubmed.ncbi.nlm.nih.gov/12814555" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Biol&amp;title=Role+of+VEGF&#x02010;A+in+vascularization+of+pancreatic+islets&amp;volume=13&amp;publication_year=2003&amp;pages=1070-1074&amp;pmid=12814555&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0029">29. <span class="mixed-citation" id="jcmm13993-cit-0029">
Kamba T, Tam BY, Hashizume H, et&#x000a0;al. <span class="ref-title">VEGF&#x02010;dependent plasticity of fenestrated capillaries in the normal adult microvasculature</span>. <span class="ref-journal">Am J Physiol Heart Circ Physiol</span>. 2006;<span class="ref-vol">290</span>:H560&#x02010;H576. [<a href="https://pubmed.ncbi.nlm.nih.gov/16172168" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Heart+Circ+Physiol&amp;title=VEGF&#x02010;dependent+plasticity+of+fenestrated+capillaries+in+the+normal+adult+microvasculature&amp;volume=290&amp;publication_year=2006&amp;pages=H560-H576&amp;pmid=16172168&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0030">30. <span class="mixed-citation" id="jcmm13993-cit-0030">
Strickland LA, Jubb AM, Hongo JA, et&#x000a0;al. <span class="ref-title">Plasmalemmal vesicle&#x02010;associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor&#x02010;A (VEGF)</span>. <span class="ref-journal">J Pathol</span>. 2005;<span class="ref-vol">206</span>:466&#x02010;475. [<a href="https://pubmed.ncbi.nlm.nih.gov/15971170" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pathol&amp;title=Plasmalemmal+vesicle&#x02010;associated+protein+(PLVAP)+is+expressed+by+tumour+endothelium+and+is+upregulated+by+vascular+endothelial+growth+factor&#x02010;A+(VEGF)&amp;volume=206&amp;publication_year=2005&amp;pages=466-475&amp;pmid=15971170&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0031">31. <span class="mixed-citation" id="jcmm13993-cit-0031">
Hnasko R, Carter JM, Medina F, et&#x000a0;al. <span class="ref-title">PV&#x02010;1 labels trans&#x02010;cellular openings in mouse endothelial cells and is negatively regulated by VEGF</span>. <span class="ref-journal">Cell Cycle</span>. 2006;<span class="ref-vol">5</span>:2021&#x02010;2028. [<a href="https://pubmed.ncbi.nlm.nih.gov/16969078" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Cycle&amp;title=PV&#x02010;1+labels+trans&#x02010;cellular+openings+in+mouse+endothelial+cells+and+is+negatively+regulated+by+VEGF&amp;volume=5&amp;publication_year=2006&amp;pages=2021-2028&amp;pmid=16969078&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0032">32. <span class="mixed-citation" id="jcmm13993-cit-0032">
Hnasko R, Frank PG, Ben&#x02010;Jonathan N, et&#x000a0;al. <span class="ref-title">PV&#x02010;1 is negatively regulated by VEGF in the lung of caveolin&#x02010;1, but not caveolin&#x02010;2, null mice</span>. <span class="ref-journal">Cell Cycle</span>. 2006;<span class="ref-vol">5</span>:2012&#x02010;2020. [<a href="https://pubmed.ncbi.nlm.nih.gov/16969073" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Cycle&amp;title=PV&#x02010;1+is+negatively+regulated+by+VEGF+in+the+lung+of+caveolin&#x02010;1,+but+not+caveolin&#x02010;2,+null+mice&amp;volume=5&amp;publication_year=2006&amp;pages=2012-2020&amp;pmid=16969073&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0033">33. <span class="mixed-citation" id="jcmm13993-cit-0033">
Paes KT, Wang E, Henze K, et&#x000a0;al. <span class="ref-title">Frizzled 4 is required for retinal angiogenesis and maintenance of the blood&#x02010;retina barrier</span>. <span class="ref-journal">Invest Ophthalmol Vis Sci</span>. 2011;<span class="ref-vol">52</span>:6452&#x02010;6461. [<a href="https://pubmed.ncbi.nlm.nih.gov/21743011" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+Ophthalmol+Vis+Sci&amp;title=Frizzled+4+is+required+for+retinal+angiogenesis+and+maintenance+of+the+blood&#x02010;retina+barrier&amp;volume=52&amp;publication_year=2011&amp;pages=6452-6461&amp;pmid=21743011&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0034">34. <span class="mixed-citation" id="jcmm13993-cit-0034">
Schafer NF, Luhmann UF, Feil S, et&#x000a0;al. <span class="ref-title">Differential gene expression in Ndph&#x02010;knockout mice in retinal development</span>. <span class="ref-journal">Invest Ophthalmol Vis Sci</span>. 2009;<span class="ref-vol">50</span>:906&#x02010;916. [<a href="https://pubmed.ncbi.nlm.nih.gov/18978344" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+Ophthalmol+Vis+Sci&amp;title=Differential+gene+expression+in+Ndph&#x02010;knockout+mice+in+retinal+development&amp;volume=50&amp;publication_year=2009&amp;pages=906-916&amp;pmid=18978344&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0035">35. <span class="mixed-citation" id="jcmm13993-cit-0035">
Zhou Y, Wang Y, Tischfield M, et&#x000a0;al. <span class="ref-title">Canonical WNT signaling components in vascular development and barrier formation</span>. <span class="ref-journal">J Clin Invest</span>. 2014;<span class="ref-vol">124</span>:3825&#x02010;3846. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4151216/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25083995" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Canonical+WNT+signaling+components+in+vascular+development+and+barrier+formation&amp;volume=124&amp;publication_year=2014&amp;pages=3825-3846&amp;pmid=25083995&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0036">36. <span class="mixed-citation" id="jcmm13993-cit-0036">
Liebner S, Corada M, Bangsow T, et&#x000a0;al. <span class="ref-title">Wnt/beta&#x02010;catenin signaling controls development of the blood&#x02010;brain barrier</span>. <span class="ref-journal">J Cell Biol</span>. 2008;<span class="ref-vol">183</span>:409&#x02010;417. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2575783/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18955553" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biol&amp;title=Wnt/beta&#x02010;catenin+signaling+controls+development+of+the+blood&#x02010;brain+barrier&amp;volume=183&amp;publication_year=2008&amp;pages=409-417&amp;pmid=18955553&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0037">37. <span class="mixed-citation" id="jcmm13993-cit-0037">
Covassin L, Amigo JD, Suzuki K, et&#x000a0;al. <span class="ref-title">Global analysis of hematopoietic and vascular endothelial gene expression by tissue specific microarray profiling in zebrafish</span>. <span class="ref-journal">Dev Biol</span>. 2006;<span class="ref-vol">299</span>:551&#x02010;562. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1779954/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16999953" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dev+Biol&amp;title=Global+analysis+of+hematopoietic+and+vascular+endothelial+gene+expression+by+tissue+specific+microarray+profiling+in+zebrafish&amp;volume=299&amp;publication_year=2006&amp;pages=551-562&amp;pmid=16999953&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0038">38. <span class="mixed-citation" id="jcmm13993-cit-0038">
Farber G, Hurtado R, Loh S, et&#x000a0;al. <span class="ref-title">Glomerular endothelial cell maturation depends on ADAM10, a key regulator of Notch signaling</span>. <span class="ref-journal">Angiogenesis</span>. 2018;<span class="ref-vol">21</span>:335&#x02010;347. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5878725/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29397483" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Angiogenesis&amp;title=Glomerular+endothelial+cell+maturation+depends+on+ADAM10,+a+key+regulator+of+Notch+signaling&amp;volume=21&amp;publication_year=2018&amp;pages=335-347&amp;pmid=29397483&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0039">39. <span class="mixed-citation" id="jcmm13993-cit-0039">
Chang AC, Fu Y, Garside VC, et&#x000a0;al. <span class="ref-title">Notch initiates the endothelial&#x02010;to&#x02010;mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase</span>. <span class="ref-journal">Dev Cell</span>. 2011;<span class="ref-vol">21</span>:288&#x02010;300. [<a href="https://pubmed.ncbi.nlm.nih.gov/21839921" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dev+Cell&amp;title=Notch+initiates+the+endothelial&#x02010;to&#x02010;mesenchymal+transition+in+the+atrioventricular+canal+through+autocrine+activation+of+soluble+guanylyl+cyclase&amp;volume=21&amp;publication_year=2011&amp;pages=288-300&amp;pmid=21839921&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0040">40. <span class="mixed-citation" id="jcmm13993-cit-0040">
Mintet E, Lavigne J, Paget V, et&#x000a0;al. <span class="ref-title">Endothelial Hey2 deletion reduces endothelial&#x02010;to&#x02010;mesenchymal transition and mitigates radiation proctitis in mice</span>. <span class="ref-journal">Sci Rep</span>. 2017;<span class="ref-vol">7</span>:4933. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5503994/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28694461" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Rep&amp;title=Endothelial+Hey2+deletion+reduces+endothelial&#x02010;to&#x02010;mesenchymal+transition+and+mitigates+radiation+proctitis+in+mice&amp;volume=7&amp;publication_year=2017&amp;pages=4933&amp;pmid=28694461&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0041">41. <span class="mixed-citation" id="jcmm13993-cit-0041">
Stan RV. <span class="ref-title">Multiple PV1 dimers reside in the same stomatal or fenestral diaphragm</span>. <span class="ref-journal">Am J Physiol Heart Circ Physiol</span>. 2004;<span class="ref-vol">286</span>:H1347&#x02010;H1353. [<a href="https://pubmed.ncbi.nlm.nih.gov/14630628" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Heart+Circ+Physiol&amp;title=Multiple+PV1+dimers+reside+in+the+same+stomatal+or+fenestral+diaphragm&amp;volume=286&amp;publication_year=2004&amp;pages=H1347-H1353&amp;pmid=14630628&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0042">42. <span class="mixed-citation" id="jcmm13993-cit-0042">
Schmittgen TD, Livak KJ. <span class="ref-title">Analyzing real&#x02010;time PCR data by the comparative C(T) method</span>. <span class="ref-journal">Nat Protoc</span>. 2008;<span class="ref-vol">3</span>:1101&#x02010;1108. [<a href="https://pubmed.ncbi.nlm.nih.gov/18546601" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Protoc&amp;title=Analyzing+real&#x02010;time+PCR+data+by+the+comparative+C(T)+method&amp;volume=3&amp;publication_year=2008&amp;pages=1101-1108&amp;pmid=18546601&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0043">43. <span class="mixed-citation" id="jcmm13993-cit-0043">
Chesnokov MS, Khesina PA, Shavochkina DA, et&#x000a0;al. <span class="ref-title">Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinoma</span>. <span class="ref-journal">PeerJ</span>. 2018;<span class="ref-vol">6</span>:e4915. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5993022/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29888133" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PeerJ&amp;title=Shift+in+VEGFA+isoform+balance+towards+more+angiogenic+variants+is+associated+with+tumor+stage+and+differentiation+of+human+hepatocellular+carcinoma&amp;volume=6&amp;publication_year=2018&amp;pages=e4915&amp;pmid=29888133&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0044">44. <span class="mixed-citation" id="jcmm13993-cit-0044">
Schneider&#x02010;Poetsch T, Ju J, Eyler DE, et&#x000a0;al. <span class="ref-title">Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin</span>. <span class="ref-journal">Nat Chem Biol</span>. 2010;<span class="ref-vol">6</span>:209&#x02010;217. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2831214/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20118940" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Chem+Biol&amp;title=Inhibition+of+eukaryotic+translation+elongation+by+cycloheximide+and+lactimidomycin&amp;volume=6&amp;publication_year=2010&amp;pages=209-217&amp;pmid=20118940&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0045">45. <span class="mixed-citation" id="jcmm13993-cit-0045">
Jeffrey D, Esko JHP, Linhardt RJ. Proteins that bind sulfated glycosaminoglycans In: Varki A, Cummings RD, Esko JD, eds. <span class="ref-journal">Essentials of Glycobiology</span>, 2nd edition
Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2009. 
 10.1101/glycobiology.3e.038. [<a href="https://pubmed.ncbi.nlm.nih.gov/20301268" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1101%2Fglycobiology.3e.038" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Essentials+of+Glycobiology&amp;publication_year=2009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0046">46. <span class="mixed-citation" id="jcmm13993-cit-0046">
Burns DL. <span class="ref-title">Subunit structure and enzymic activity of pertussis toxin</span>. <span class="ref-journal">Microbiol Sci</span>. 1988;<span class="ref-vol">5</span>:285&#x02010;287. [<a href="https://pubmed.ncbi.nlm.nih.gov/2908558" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Microbiol+Sci&amp;title=Subunit+structure+and+enzymic+activity+of+pertussis+toxin&amp;volume=5&amp;publication_year=1988&amp;pages=285-287&amp;pmid=2908558&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0047">47. <span class="mixed-citation" id="jcmm13993-cit-0047">
Griffith JW, Sokol CL, Luster AD. <span class="ref-title">Chemokines and chemokine receptors: positioning cells for host defense and immunity</span>. <span class="ref-journal">Annu Rev Immunol</span>. 2014;<span class="ref-vol">32</span>:659&#x02010;702. [<a href="https://pubmed.ncbi.nlm.nih.gov/24655300" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Immunol&amp;title=Chemokines+and+chemokine+receptors:+positioning+cells+for+host+defense+and+immunity&amp;volume=32&amp;publication_year=2014&amp;pages=659-702&amp;pmid=24655300&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0048">48. <span class="mixed-citation" id="jcmm13993-cit-0048">
Leung DW, Cachianes G, Kuang WJ, et&#x000a0;al. <span class="ref-title">Vascular endothelial growth factor is a secreted angiogenic mitogen</span>. <span class="ref-journal">Science</span>. 1989;<span class="ref-vol">246</span>:1306&#x02010;1309. [<a href="https://pubmed.ncbi.nlm.nih.gov/2479986" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Vascular+endothelial+growth+factor+is+a+secreted+angiogenic+mitogen&amp;volume=246&amp;publication_year=1989&amp;pages=1306-1309&amp;pmid=2479986&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0049">49. <span class="mixed-citation" id="jcmm13993-cit-0049">
Namiki A, Brogi E, Kearney M, et&#x000a0;al. <span class="ref-title">Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells</span>. <span class="ref-journal">J Biol Chem</span>. 1995;<span class="ref-vol">270</span>:31189&#x02010;31195. [<a href="https://pubmed.ncbi.nlm.nih.gov/8537383" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Hypoxia+induces+vascular+endothelial+growth+factor+in+cultured+human+endothelial+cells&amp;volume=270&amp;publication_year=1995&amp;pages=31189-31195&amp;pmid=8537383&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0050">50. <span class="mixed-citation" id="jcmm13993-cit-0050">
Ewenstein BM, Warhol MJ, Handin RI, et&#x000a0;al. <span class="ref-title">Composition of the von Willebrand factor storage organelle (Weibel&#x02010;Palade body) isolated from cultured human umbilical vein endothelial cells</span>. <span class="ref-journal">J Cell Biol</span>. 1987;<span class="ref-vol">104</span>:1423&#x02010;1433. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2114468/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3494734" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biol&amp;title=Composition+of+the+von+Willebrand+factor+storage+organelle+(Weibel&#x02010;Palade+body)+isolated+from+cultured+human+umbilical+vein+endothelial+cells&amp;volume=104&amp;publication_year=1987&amp;pages=1423-1433&amp;pmid=3494734&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm13993-bib-0051">51. <span class="mixed-citation" id="jcmm13993-cit-0051">
Simons M, Gordon E, Claesson&#x02010;Welsh L. <span class="ref-title">Mechanisms and regulation of endothelial VEGF receptor signalling</span>. <span class="ref-journal">Nat Rev Mol Cell Biol</span>. 2016;<span class="ref-vol">17</span>:611&#x02010;625. [<a href="https://pubmed.ncbi.nlm.nih.gov/27461391" ref="reftype=pubmed&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Mol+Cell+Biol&amp;title=Mechanisms+and+regulation+of+endothelial+VEGF+receptor+signalling&amp;volume=17&amp;publication_year=2016&amp;pages=611-625&amp;pmid=27461391&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6349158&amp;issue-id=328370&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Journal of Cellular and Molecular Medicine</span> are provided here courtesy of <strong>Blackwell Publishing</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC6349158/pdf/JCMM-23-920.pdf" class="int-view">PDF (1.2M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/6349158/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/6349158/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="6349158" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6349158%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="ED8sKITfeodK8luTDZM0IMD6S3rF1C1yr2HVXcpdH9eVqn0PWbGfHYwu3DLQopCx">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6349158%2F&amp;text=Phorbol%20esters%20induce%20PLVAP%20expression%20via%20VEGF%20and%20additional%20secreted%20molecules%20in%20MEK1%02010dependent%20and%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6349158%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349158/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC6349158/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/30394679/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC6349158/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/30394679/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC6349158/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/6349158/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC6349158/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
